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Abstract
A comprehensive review is presented on the current trends in sample preparation for
isolation of veterinary drugs and growth promotors from foods. The objective of the
review is to firstly give an overview of the sample preparation techniques that are
applied in field. The review will focus on new techniques and technologies, which
improve efficiency and coverage of residues. The underlying theme to the paper is
the developments that have been made in multi-residue methods and particularly
multi-class methods for residues of licensed animal health products, which have been
developed in the last couple of years. The role of multi-class methods is discussed
and how they can be accommodated in future residue surveillance.
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1. Introduction
Sample preparation is the process of extracting chemical residues from a sample and
the subsequent purification of the extract to isolate the residues of interest and remove
any matrix interferents that may affect the detection system. Even with the
advancement of separation and detection techniques, sample preparation is a vital part
of the analytical process and effective sample preparation is essential for achieving
reliable results and maintaining instrument performance. Sample preparation in
residue analysis is often not covered well in literature with many review papers
focusing on detection systems. However, a number of good general review papers
have reported on the topic of sample preparation specifically [1-4]. Some book
chapters provide a more in-depth analysis of the area, but with the rapid progression
of sample preparation in recent years, most book chapters are a little outdated at
present [5,6].
There have been quite a number of changes in the approach to preparing samples in
recent years due to the widespread application of mass spectrometry. While in the
past, methods were only capable of analysing lower numbers of residues (usually a
single class of drug) [7-1 1], mass spectrometry now offers the possibility to analyse
vast numbers of residues in a single run [12-15]. As a result, there is now a tendency
to focus towards more generic extraction and clean-up procedures to cover the wide
range of veterinary drugs that can be found in food of animal origin [15-17].
Although the use of mass spectrometry permits the use of simpler generic clean-up
methods, effective removal of matrix constituents is necessary as these may affect the
performance of the mass spectrometer, particularly ion suppression and enhancement
effects [18]).
Besides classical liquid-liquid extraction, liquid-liquid partitioning and the well-
established solid-phase extraction, a number of new formats have now found
applications in residue analysis. QuEChERS [16,17], ultra-filtration [19], on-line SPE
[20] and high throughput approaches such as 96-well plates are now beginning to find
application in the area. There is a constant need for new techniques that are faster,
cheaper, require less solvent and are amenable to automation.
This paper will firstly present a brief overview of the main techniques currently being
applied in this area, particularly with a focus on new developments which improve
efficiency. Coverage of specific techniques is not intended to be comprehensive and
readers seeking a more detailed discussion should refer to the reference papers or
books cited in the text. The paper will then review a selection of methods for
isolating residues in different biological matrices. The paper largely focuses on multi-
residue or multi-class assays that employ selective LC-MS detection.
2. The Sample
2.1 Sample selection
Several edible tissues from food producing animals can be selected for residue
surveillance including muscle, liver, kidney, skin and fat, which are normally taken at
slaughter houses. In addition, further sample matrix types can be taken on farm or at
production sites, including milk, honey, eggs and fish. The approach normally
adopted in residue surveillance is to target the matrix where residues are most
persistent for Group A substances (banned substances) and at their highest
concentration for Group B substances (licensed veterinary drugs). Sample matrix
selection for imported foods is limited to traded commodities such as muscle, honey,
milk and eggs. Muscle is a particularly advantageous tissue for residue surveillance
because it is the main tissue consumed and can be used to analyse both imported and
domestic samples, thereby reducing laboratory validation requirements. However,
muscle can present analytical difficulties because of variability in residue distribution
[21-23], particularly in the area surrounding injection sites [24-27]. There is also the
concern of lower probability of finding non-compliant samples compared to matrices
such as liver and kidney [28].
Samples for Group A include plasma/serum, urine, faeces, H2O, feed, bile (abattoir)
and thyroid gland (abattoir), which can be taken on-farm or at abbattoir. Alternative
matrices allow detection of residues for (i) longer periods post treatment (e.g. β-
agonists in retina [29-33] and steroids in hair [34]), (ii) discrimination between
endogeneous and exogeneous sources of anabolic agents (steroid esters in urine [35])
or (iii) to allow detection of residues using less complicated equipment (e.g. HPLC
detection of semicarbazide in retina [36]).
2.2 Sample storage and preservation
Sample storage is an important step, because of the lag time between sample
collection and analysis. Both physico-chemical factors (oxidation, proteolysis and
precipitation) and biological factors (microbiological and enzymatic reactions) need to
be considered when storing samples. Some studies have reported on the presence of
micro-organisms which produce the enzyme penicillinase, which are capable of
reducing the concentration of penicillin in kidney tissue stored at 4°C [37]. However,
preservation can be achieved through the addition of enzyme inhibitors (e.g. piperonyl
butoxide inhibits cytochrome P450). A number of studies have highlighted the
degradation of residues during frozen storage, namely β-lactam antibiotics in milk
[38], ampicillin in pig muscle [39], chlortetracycline in incurred pig muscle, liver
and kidney [40], sulphamethazine in incurred pig muscle and bovine milk [41], and
gentamicin residues in egg [42]. EU validation criteria describe guidelines for
stability studies to be carried out during method validation [43]. Stability should be
determined for the analytes in matrix and in solution at various stages of the sample
preparation process. Whenever possible, incurred tissue should be used, otherwise
matrix fortified material is used. A practical approach is to run a test to see how long
a sample and/or analyte can be held without degradation and then to complete the
analysis within that time.
2.3 Sample pre-treatment
The variation of residues within a single organ or tissue is an important factor to
consider prior to sample preparation but is often ignored. For example, residue
variations may occur in the kidney between the medulla and the cortex [44-46].
Therefore, it is important to take a representative aliquot of the sample, which may
require removal of several portions throughout the composite sample to give a
representative sample. Homogenisation with a blender is often advantageous for
obtaining a homogenous sample but can result in the release of enzymes, which can
degrade residues and provide inaccurate results. Liquid samples (blood, plasma,
serum, milk, bile or H2O) are generally easier to process than solid samples and
residues are more homogenously distributed throughout.
3. Sample extraction
3.1 Target residue
3.1.1 Free residues and conjugates
The residues present can vary greatly between target tissues due to the extensive
metabolism in animals after administration. The target residue for analysis is not
always the parent drug but can be comprised of the parent drug and/or metabolites.
The free parent and metabolite residues are readily extracted by organic solvents, H2O
or aqueous buffers. However, many residues are present in the conjugated forms
(glucoronides or sulfates) and require liberation through enzymatic or chemical
hydrolysis prior to extraction. Hydrolysis conditions (namely pH, temperature and
time) have to be carefully optimised to ensure efficient deconjugation of residues.
Enzymatic hydrolysis generally ensures milder conditions than acid or alkaline
hydrolysis. Common enzymatic preparations used for hydrolysis include Helix
promatia juice (a mixture of β-glucuronidase and arylsulphatase) and E. Coli β-
glucuronidase.
3.1.2 Bound residues
Residues bound through weak interactions can be easily extracted after dialysis,
proteolysis or denaturation of proteins by heat or acid treatments. In practice, analysis
of bound residues is applied to very few drugs, namely nitrofurans, florfenicol and
triclabendazole. Nitrofuran antibiotics are rapidly metabolised to form bound
residues, which persist for many weeks after treatment [47]. These bound metabolites
pose a health risk and are used as marker residues to monitor for nitrofurans [48]. It is
proposed that binding of residues occurs through cleavage of the nitrofuran ring by
stomach acid, leaving the specific tail group covalently bound to tissue [49]. The
bound metabolites are cleaved from tissue samples under mildly acidic conditions
before undergoing derivatisation to increase the sensitivity of detection [50].
Metabolism studies of florfenicol depletion demonstrated that non-extractable
residues of florfenicol were pre-dominant in tissues [51]. Acid hydrolysis of non-
extractable residues not only liberates bound residues, it also converts them to
florfenicol amine (FFA), which is the marker residue for florfenicol [52,53].
O‘Keeffe et al. investigated the release of bound thiabendazole residues, finding
optimum yields under alkaline conditions [54]. Acid hydrolysis, Raney nickel
catalysis and enzymatic hydrolysis (cystathionine β-lactase) were found to be largely
unsuccessful [55].
3.2 Tissue disruption
Disruption of tissue is normally achieved using a probe blender or through enzymatic
digestion with proteolytic enzymes such as subtilisin A and ronase E [56]. Several
tissue disruption apparatus are available, including probe blenders, ultrasonic probes
and stomachers. The ultrasonic probe uses pulsed, high frequency sound waves to
agitate and disperse cells. The Stomacher® is an alternative apparatus which extracts
residues from samples using crushing action. Stomachers® offer an advantage over
probe blending techniques because they eliminate the risk of cross-contamination, as
each sample is contained in separate bags.
3.2.1 High-throughput tissue disruption
A number of automated apparatus have been developed that allow unattended
disruption of samples, while significantly improving sample throughput and
reproducibility. The Omni Prep Multi-Sample HomogenizerTM is a multi-probe
blender with a specially designed oscillating sample rack capable of simultaneously
processing batches of six samples at a time. The Tomtec AutogizerTM is a more
sophisticated system that allows unattended processing of large batches of tissue
samples using either five probe blenders or two ultrasonic probes at a time. A major
advantage of the system is a three staged automated cleaning program using (a)
aqueous, (b) organic and (c) ultrasonic cleaning cycles. The FASTH 21TM
homogeniser system is an alternative tissue disruption system, which uses disposable
tubes containing rotating blades. Samples are fed in racks, four at a time, in a
conveyor belt system and homogenised at high speed. In theory, the system can
process as many as 250 samples per hour. In practice, the FASTH 21TM system
provides excellent homogenisation of samples but drawbacks of the system include
the tendency of the propeller stem to break during homogenisation and the inability to
undergo further sample manipulation such as shaking (due to leakage). However, it is
proposed through future improvements in tube design that these problems can be
resolved.
3.2.2 Evaluation of disruption techniques
The majority of methods in the literature report extraction efficiency (or recovery)
using fortified samples. While these artificial systems may demonstrate recovery
efficiency during sample preparation, they may not accurately represent the true
residue content from a naturally incurred test sample. The total residue concentration
in a naturally incurred sample may be difficult to measure due to tight or irreversible
binding of residues to matrix components. McCracken et al. compared the
extractability of chlortetracycline (CTC), sulphadiazine (SDZ) and flumequine (FMQ)
residues from incurred and spiked chicken muscle using four different disruption
techniques (probe blender, Stomacher®, ultrasonic bath and end-over-end mixer)
[57]. Results showed that extractability of residues from fortified samples were
similar for each technique. In contrast, the highest extraction efficiency for all three
residues from incurred tissue was achieved using probe blending.
3.3 Sample extraction techniques
3.3.1 Manual sample extraction techniques
Residues are typically extracted from samples using simple solvent extraction or
liquid-liquid extraction (LLE). The extraction technique adopted may depend on the
nature of the samples (i.e. liquid or solid) and the physico-chemical properties of the
residues (polarity and pKa). Simple extraction with aqueous buffer is advantageous
for highly polar residues because they reduce non-polar matrix components (e.g.
lipids) and extracts can be enriched on reversed phase SPE, while eliminating time
consuming evaporation steps. A disadvantage is that strongly protein-bound residues
are not fully extracted and polar matrix components are co-extracted. In general, the
majority of methods employ more efficient organic solvents as extracting agents [15].
ACN is the preferred extraction solvent as it gives good yields of residues but low
levels of matrix co-extractives and is effective at denaturing proteins and inactivating
enzymes [15]. MeOH and EtOAc are also widely used solvents but result in the
extraction of additional matrix components [15]. However, in the area of multi-
residue analysis there is always a compromise between recovery and the purity of
sample extracts.
Liquid-liquid extraction (LLE) was the most widely applied extraction procedure in
residue analysis due to its high selectivity compared to simple solvent extraction.
LLE applications can also include polar ionisable compounds, which can be extracted
by non-polar organic solvents using the ion-pair technique: transforming positively
charged substances into non-polar neutral compounds in the presence of organic
anions, or vice-versa. Examples of the successful application of ion-pair extraction
are β-agonists [58], aminoglycosides [59] and oxytetracycline [60]).
However, LLE has been replaced in recent years due to the difficulties in automating
LLE, the development of SPE and most importantly the widespread application of
more selective LC-MS/MS detection systems.
Anastassiades and co-workers developed a variation of LLE in the QuEChERS
sample preparation procedure (standing for ―quick, easy, cheap, effective, rugged and 
safe), which has been successfully applied to the analysis of hundreds of pesticide
residues [61]. In QuEChERS, the high-moisture sample (H2O is added to dry foods)
is extracted with an organic solvent (ACN, EtOAc, or acetone) in the presence of salts
(MgSO4, NaCl and/or buffering agents). The addition of salts induces phase
separation of the solvent from the aqueous phase. The residues of interest and matrix
co-extractives are separated into the relevant liquid phase based on their polarity with
the residues partitioning into the organic phase and matrix co-extractives into the
aqueous phase. Upon shaking and centrifugation, an aliquot of the organic phase is
subjected to further purification using dispersive-SPE, which entails mixing sorbents
with the extract. The approach is very flexible, and since its development there have
been several modifications to the technique depending on residues, matrices,
instrumentation, and analyst preferences [16,17,62-72]. The approach uses very little
labware and generates little waste. The technique provides high recovery for many
LC- and GC-amenable residues, gives high reproducibility, and costs less than many
typical sample preparation approaches [61]. Several groups have adapted the method
to analyse residues in a variety of matrices. HAc (1%) has been widely used to adjust
pH and promotes stability and recovery of base-sensitive residues [73]. HAc was
used to adjust pH by Stubbings and Bigwood to determine residues in chicken muscle
[17] and by Aguilera-Luiz et al. to determine 18 antibiotics in milk [72]. QuEChERS
low cost, coupled to its flexibility and ease of use will no doubt result in an increase in
its application to residue analysis.
Kaufmann et al. developed a =bi-polarity extraction‘ method based upon similar
principles as the QuEChERS technique [15]. Whereas QuEChERS is used to extract
residues of similar polarity, Kaufmann‘s aim was to develop a method capable of
extracting residues of diverse polarities (polar and non-polar). The residues (polar
and non-polar) remain in the aqueous phase, which undergoes clean-up by SPE on a
mixed-mode Oasis HLB cartridge and subsequently analysed by UPLC-MS/MS.
A major disadvantage of the bi-polarity approach is that matrix components are
extracted along with residues. The sample therefore needs to undergo a lengthy SPE
procedure to isolate the residues. However, this lengthy clean-up procedure produces
a highly pure sample extract ready for analysis. In contrast, the QuEChERS method
suspends numerous matrix components in the aqueous phase, which is discarded. The
cleaner organic phase can subsequently undergo a much simpler clean-up step
(dispersive-SPE). Although the bi-polarity extraction method was able to extract
residues with a wide polarity range, it was unable to sufficiently extract very non-
polar residues without losing polar residues in the SPE clean-up.
An alternative to QuEChERS is Matrix solid-phase dispersion (MSPD); which was a
popular sample preparation technique in residue analysis in the late 1980s and 1990s,
which combined both sample extraction and isolation in one step. Barker [74] defined
MSPD procedures as those that use dispersing sorbents with chemical modification of
the silica surface (e.g. C18, C8, etc.). For most applications, particles with diameters of
40-100 µm are used [75]. A sample is blended and dispersed with a sorbent using a
glass mortar and pestle (Fig. 1). Sample/sorbent ratios typically range from 1:1 to
1:4; with 0.5 g sample and 2 g sorbent being the most commonly used quantities. It is
important to use a glass or agate mortar and pestle as the use of ceramic/clay can
result in loss of analytes [76]. After dispersion, the sample is air-dried (5 to 15 min)
prior to compression between two frits in a syringe barrel with a syringe plunger. In
recent years, many groups have used non-bonded silica based dispersion agents such
as Na2SO4 or silica [77-80]. This is approach is advantageous because it eliminates
the air-drying step from the procedure.
The choice of wash and elution solvent are key for successful MSPD applications.
Lipophilic matrix interferents can be removed through washing with non-polar
solvents like hexane. For veterinary drugs, polar solvents, such as dichloromethane
(DCM), alcohols and hot H2O, are typically used. Hot H2O has been successfully
used by Bogialli et al. to extract several classes of drugs from various matrices [82-
88]. However, care must be taken when using hot H2O as some analytes can
thermally degrade. The major advantages of MSPD are that (a) the technique can be
applied to a wide range of residues, (b) it eliminates the need for protein precipitation
steps and (c) it eliminates the need for centrifugation. In addition, because the surface
area of the entire sample (including proteins, connective tissues, etc.) is exposed to the
solvents, more effective washing and elution of extracts can be achieved. Another
advantage is that residues can be sequentially eluted using different solvents of
increasing or decreasing polarity. There has been a resurgence of the technique in
recent years for the preparation of veterinary samples for drug residue analysis.
However, the technique has not found widespread application for routine residue
surveillance.
3.3.2 Instrumental-based extraction techniques
A number of instrumental-based extraction procedures have been developed to isolate
residues from food, including microwave, supercritical fluid and pressurised liquid
extraction systems. Advantages in using such technology include the potential for
automation, more selective isolation of residues through tuning of instrument
parameters and online clean-up of samples. Disadvantages include the limited
number of commercially available instruments, additional extraction costs and
instrumental downtime. Pressurised liquid extraction (PLE) is the most widely used
instrumental extraction technique. Several applications have also been developed
using SFE and MAE but these techniques are not widely used in routine laboratories.
3.3.2.1 Microwave-assisted extraction
Microwave-assisted extraction (MAE) uses microwave energy to heat the
solvent/sample mixture in order to partition analytes from the sample matrix into the
solvent. Using microwave energy allows the solvent to be heated rapidly: an average
extraction takes 15-30 min [89]. MAE offers high sample throughput (several
samples can be extracted simultaneously) with low solvent consumption (10-30 mL).
A good review of MAE is available by Eskilsson et al. [90]. MAE systems can
operate in two modes, open (focused MAE) or closed (pressurized MAE) vessels.
Open vessels operate at atmospheric pressure, while closed vessels are sealed and
operate under higher pressures. Closed vessel MAE operates somewhat like PLE,
since the temperature of the solvent can be increased by increasing the pressure.
MAE therefore, offers many advantages. However, solvent choice is limited, care
must be taken not to overheat the sample, additional clean-up of the samples is
generally necessary prior to analysis and MAE is not amenable to automation (on-line
extraction and detection) [89]. Akhtar et al. developed a method for MAE extraction
of fortified and incurred chloramphenicol residues in freeze-dried egg [91]. Sample
extraction time was 10 s using a binary solvent mixture consisting of ACN and 2-
propanol. Akhtar also compared MAE with conventional extraction (homogenisation,
vortexing) for the determination of incurred salinomycin in chicken eggs and tissues
[92].
3.3.2.2 Supercritical fluid extraction
A supercritical fluid (SF) is defined as any substance that is above its critical
temperature and pressure [93]. The physical properties of a supercritical fluid are
intermediate between those of the liquid and gas phases; the solvating power (density)
of an SF is similar to that of a liquid and its diffusivity and viscosity are similar to that
of a gas [94]. The effectiveness of SFE is due to large changes in solvating power
achieved with minor changes in density (i.e. temperature and pressure) of the SF
around the critical point. Higher pressures are necessary to obtain liquid-like densities
for temperatures further above the critical limit. Carbon dioxide (CO2) is the most
widely used SF because of its inertness, low cost, high purity, low toxicity and low
critical parameters (CO2: Tc = 31.3°C, Pc = 72.9 atm) [95]. However, the solvating
power of supercritical CO2 at high density is not always sufficient to extract an
analyte [89]. If the analyte is not soluble or is strongly bound to the matrix a more
polar SF (e.g. N2O or CHF3) can be used, otherwise a polar modifier (MeOH, EtOH
or H2O) may be added to the SF in order to increase the solvating power [93]. Several
SFE applications have been reported in peer reviewed literature for selective isolation
of residues from food (Table 3-23). This demonstrates that the SFE is an effective
technique and can extract a wide range of residues from complex matrices. However,
particular disadvantages are the lack of automated SFE systems and limited pressure
range of some systems. This has resulted in reduced interest in the area of residue
analysis in the last 10 years.
3.3.2.3 Pressurised liquid extraction
Pressurised liquid extraction (PLE) has received numerous names, such as accelerated
solvent extraction (ASE), pressurized fluid extraction (PFE), pressurised hot solvent
extraction (PH SE), subcritical solvent extraction (S SE) and hot H2O extraction
(HWE) [96]. PLE is carried out at temperatures above the boiling point of the solvent
and uses high pressure to maintain the solvent in the liquid phase and achieve fast and
efficient extraction of analytes from the solid matrix [96]. HWE is increasingly being
used in residue analysis due to low cost, low toxicity and ease of disposal. At ambient
temperature and pressure H2O is a polar solvent, but if the temperature and pressure
are increased the polarity decreases considerably and H2O can be used to extract
medium to low polarity analytes [96,97].
A schematic of ASE system is shown in Fig. 2. At elevated temperature and pressure,
the PLE extraction process proceeds faster but selectivity decreases [98] and the
analytes are not the only compounds solubilised. Even after optimisation of all the
extraction parameters, matrix interferents (e.g. lipids, collagen, protein) are frequently
co-extracted, thereby requiring the sample to undergo further clean-up. Post-
extraction clean-up steps can be done manually, although automation of the process is
favoured. In particular, in-situ clean-up steps have been developed to offer a fast and
efficient link between extraction and analysis. The most widely used clean-up
methods are pre-PLE, MSPD and SPE. Pre-PLE involves an initial PLE extraction
with a non-polar solvent (e.g. hexane) to eliminate the hydrophobic compounds
present in the sample prior to extracting analytes of interest. SPE may be coupled on-
line to the extractor outlet and can provide clean-up and concentration in one step.
When dealing with fatty samples, addition of fat-retaining sorbents, such as Florisil®
(synthetic magnesium silicate), alumina or silica gel, prior to analysis can prevent
lipids and other interferents from being co-extracted. Although preparation of the
extraction cell is time-consuming and tedious [98], the short extraction times, the use
of low solvent volumes, the ability to use H2O (cheap and environmentally friendly)
as extraction solvent and the fact it is amenable to automation makes PLE a very
attractive option for residue analysis. A number of PLE applications have been
developed in residue analysis and are listed in Table 3-23.
4. Sample purification
4.1 Solid phase extraction
SPE is the most important sample purification technique in residue analysis and has
gradually replaced LLE and LLP. The objective of this section is to give a brief
overview of SPE and sorbent materials. A number of books and review papers have
already been written on this topic and can be consulted for more detail [6,99-105].
Conventional SPE phases used in residue analysis and their characteristics are
described in Table 1. However, these are being replaced more and more by
polymeric sorbents that offer advantages for analytes that are difficult to purify on
conventional phases shown in Table 2 [104]. It is expected that this trend will
continue in the future with the development of multi-class residue methods.
However, continued advantages of SPE include difficulties in achieving consistent
flow and plugging of cartridges, which can lead to difficulties in automation. Disk
extraction format overcomes these difficulties but have yet to find widespread
application in residue analysis. In addition, there is a question if they provide
sufficient sample load capacity and sufficient analyte retention, particularly when
dealing with multi-residues representing different chemical classes. The use of disks
should increase in the future as they offer not only better performance but also faster
extraction speeds [1].
4.2 Dispersive-SPE
Dispersive-SPE (DSPE) is a clean-up technique that involves mixing sorbent with a
sample that has been pre-extracted with an appropriate solvent. It is typically part of
the QuEChERS method where it follows the bi-polarity extraction step. The
appropriate sorbent adsorbs matrix co-extractives onto its surface, leaving analytes of
interest in the solvent. MgSO4 is added to provide additional clean-up by removing
residual H2O and some other compounds via chelation [73]. Afterwards, the mixture
is centrifuged and the resulting supernatant can be analyzed directly or can be
subjected to a concentration and/or solvent exchange step if necessary. It is an
extremely fast, simple and inexpensive process that provides high recovery and
reproducibility for many LC- and GC-amenable analytes [63].
The principal of the process is the removal of matrix compounds, while leaving the
analytes of interest in the solvent. The physico-chemical properties of the analytes
and matrix compounds determine the choice of sorbent. In pesticide analysis, primary
secondary amine (PSA) is the most common sorbent used. PSA is effective at
retaining fatty acids and other organic acids present in food [61]. For food of animal
origin, which has higher lipid content, C18 or a combination of PSA/C18 is more
effective because C18 removes lipophilic compounds. In recent research, our research
group found that the combination of PSA/C18 to provide better clean-up than PSA or
C18 alone for 38 anthelmintics in liver and milk [16]. However, PSA/C18 gave a lower
recovery for some analytes (due to PSA), compared with C18 which gave sufficient
clean-up and good recovery for all analytes and was therefore chosen as the preferred
sorbent. Graphitised carbon black (GCB) has been reported to be a highly effective
sorbent for sample clean-up [63]. However, GCB also removes structurally planar
analytes and is therefore not useful in many applications. Addition of HAc to the
extraction solvent may help to improve recovery of analytes but it also inhibits PSAs
ability to retain acidic matrix compounds [73]. Several papers have reported the use
of C18 for DSPE in veterinary residue analysis [16,62,64,71]. PSA, NH2 and silica
have also been reported [17,67,71]. DSPE does not provide the same degree of clean-
up as SPE. However, it does provide good recovery and reproducibility, coupled with
practical and cost advantages [61].
4.3 Immunoaffinity chromatography
A number of good review papers have been published on immunoaffinity
chromatography (IAC) and should be consulted for a more detailed overview of this
topic [116-121]. A number of IAC applications from peer reviewed literature are
shown in Tables 3-23. It can be seen that IAC is particularly advantageous when low
detection levels in the µg kg-1 to ng kg-1 are required for banned substances,
particularly when using less selective HPLC based detection systems. However, it is
difficult to see the practical application of this technique in the isolation of residues of
licensed veterinary drug from food where there is now a trend to move towards multi-
class residue methods with detection by LC-MS/MS. Despite this, there are some
very good multi-residue applications of IAC in residue analysis [122-124]. While
most of these IAC applications have been developed by researchers, a wide range of
IAC columns are commercially available from vendors such as Rhone Diagnostics
Technologies, Biocode, r-Biopharm, Tecna, Randox and Euro-Diagnostica.
4.4 Molecularly imprinted polymers
Molecularly imprinted polymers (MIPs) are engineered cross-linked polymers that
exhibit high affinity and selectivity towards a target compound or class of structurally
related compounds (Fig. 3) [125,126]. MIPs can be tailored to selectively extract
analytes present in complex matrices such as blood, urine, tissue or feed [127]. These
materials have demonstrated binding to trace levels of target analytes, and display
high selectivity in the presence of other compounds that have similar physico-
chemical properties, as well as being extremely stable [128]. A drawback of the
technique is the potential leaching or template remaining in the MIP [129], and also
binding site heterogeneity, leading to a range of binding affinities for the target
analyte. Aqueous samples, such as milk or urine, generally require purification prior
to M IP clean-up. However, there are applications reported that apply the aqueous
sample directly to MIP without undergoing an initial extraction step [130].
4.5 Molecular weight cut-off devices
4.5.1 Ultra-filtration
The development of multi-residue assays using LC-MS/MS detection has resulted in
the alternative purification systems in the field of residue analysis such as ultra-
filtration (UF). In residue analysis of food, UF is primarily used to separate analytes
of interest from macro-molecules, such as proteins, peptides, lipids and sugars, which
may interfere with analysis, particularly affecting ionisation in mass spectrometry. In
residue analysis, molecular weigh cut-off devices or spin filters coupled to micro
centrifuge tubes are the most commonly used formats. Alternative formats are also
available such as 96-well plate, but require dedicated vacuum manifolds and pumps.
However, all residue applications use centrifugal devices. Examples of applications
include sulphonamides in milk [19,132-134], eggs [132,135,136], plasma [137] and
edible tissues [138,139], benzimidazoles in milk [19], tetracyclines in egg [140], β-
agonist in urine [141], penicillin G in muscle, kidney and liver [142], and spiramycin
(a macrolide) in egg and chicken muscle [143].
4.5.2 Size exclusion or gel permeation chromatography
This mode of purification is widely used in the area of pesticide residue analysis.
These materials usually have the appearance of a gel, resulting in the generic name gel
permeation chromatography (GPC). Purification is achieved through molecular
sieving, which occurs through pores on the surface of a solid sorbent. Size exclusion
is not very specific and lacks resolving power, with frequent overlap between similar
sized molecules, independent of their chemical structure or properties. However, it
can be successfully used to separate low molecular weight drugs from larger
interferents (proteins, carbohydrates, triglycerides, etc). Few publications report the
use of GPC in residue analysis, although it has been successfully used in the analysis
of sulphonamides in shrimp [144], thyreostats in thyroid samples [145] and
sulphonamides, nitrofurans and growth promoters in animal feed [146].
4.6 High-throughput sample preparation
Recently, there has been a move from slow manual sample preparation techniques to
faster automated techniques. Automated sample preparation can be carried out on-
line (connected directly to the analysis system) or off-line (sample preparation is
automated, but the sample has to be manually transferred to the analysis system).
Automated sample preparation offers the ability to perform sample clean-up,
concentration and analyte separation in a closed system. This reduces the sample
preparation time and the whole sample becomes available for analysis, while
sensitivity and limits of detection are improved accordingly. It also removes some of
the human element from a procedure, thereby improving precision and
reproducibility. Furthermore, automated sample preparation reduces cost by using
less solvent and fewer personnel. However, there is an increase in initial capital
expenditure. Other advantages include reduced risk of sample contamination and
elimination of analyte losses by evaporation or by degradation during sample pre-
concentration.
4.6.1 Automated off-line/on-line SPE
Off-line is more common than on-line systems because it can be applied to traditional
SPE clean-up. A disadvantage is that extracts require concentration and have to be
transferred manually to the analytical system. A particular advantage over some on-
line SPE systems is that memory or sample carry over effects are eliminated through
single use SPE cartridges. The Gilson ASPEC XLTM is a typical example of an
automated off-line SPE system that can process four samples in parallel in cartridge
and 96-well format. A number of applications have been developed using this
platform including anabolic steroids in urine [147,148]; quinolones in animal feed
[149], seafood [150], bovine plasma, milk and tissues [151]; stilbenes in animal
tissues [152]; sulphonamides in ovine plasma [153]; macrocyclic lactones in liver
[154] and plasma [155,156]; benzimidazoles in bovine liver [106]; halofuginone in
chicken liver and eggs [157]; malachite green in trout muscle [158]; carbadox and
olaquindox in porcine liver [159].
As an alternative, automated purification of samples can be achieved through on-line
SPE. In this process the extraction cartridge is inserted in place of the sample
injection loop, thus allowing simultaneous samples preparation and chromatographic
analysis. On-line SPE offers better control of the sample preparation process and
improved sensitivity through more selective isolation of target residues. A
disadvantage of this approach is that some substances can carryover between
injections and result in a memory effect. Spark Holland have developed an on-line
system (Symbiosis®) based on disposable single-use-cartridges, which are
automatically replaced for each sample to eliminate memory effects (Fig. 4). The
Symbiosis automated SPE unit has been successfully used in the analysis of β-lactams
in bovine milk [160], benzimidazoles in milk [161], tetracyclines in milk [162] and
chloramphenicol in egg [163].
4.6.2 Turbulent flow chromatography
Turbulent flow chromatography (TFC) is a high-throughput sample preparation
technique that utilizes high flow rates (4-6 mL) and an analytical column containing
sorbent particles with large pore sizes (30-60 µm). Due to the large pore size, there is
only moderate back-pressure on the column, which serves as both extraction and
analytical column. At the higher flow rate, solvent doesn‘t exhibit laminar flow but
exhibits turbulent flow instead. This leads to the formation of eddies which promote
cross-channel mass transfer and diffusion of the analytes into the particle pores.
Samples are applied to the column using aqueous mobile phase (Fig. 5). Small
molecules diffuse more extensively than macromolecules (e.g. proteins, lipids, sugars)
and are driven into the pores of the sorbent. Due to the high flow rate, the larger
molecules are flushed to waste and don‘t have an opportunity to diffuse into the
particle pores. The trapped analytes are desorbed from the TFC column by back-
flushing it with a polar organic solvent and the eluate can be transferred with a
switching valve onto the HPLC system (normal low flow rate) for further separation
and subsequent detection (usually by MS/MS). During LC-MS/MS analysis, the TFC
column is reconditioned and primed for the next sample.
Although tissue samples need to be extracted with an organic solvent/buffer, liquid
sample preparation can be kept to a minimum and usually involves centrifugation,
internal standard addition and transfer to a vial or 96-well plate. Simple HPLC pumps
and switching valves can be used to carry out TFC, although specialist equipment,
termed high turbulent liquid chromatography (HTLC), is also available. The columns
used for TFC contain common HPLC sorbents but of larger particle sizes. The
chromatographic efficiency of TFC is similar to that of laminar flow but at much
lower flow rates. TFC is also effective at separating residues that are bound to sample
proteins [165]. The use of TFC eliminates time-consuming sample clean-up in the
laboratory and results in a much shorter analysis time, higher productivity and
reduced solvent consumption without sacrificing sensitivity or reproducibility.
Mottier et al. carried out quantitative analysis of 16 quinolones in honey using TFC
coupled on-line to LC-MS/MS [166]. Sample preparation involved simple dilution
with H2O followed by filtration and transfer of an aliquot into a vial. Sample
extraction time was 4.5 min, while the overall analysis took 18.5 min. Recovery of
the method ranged from 85 to 127%, while the LOD of the method was 5 µg kg-1.
Krebber et al. used TFC-MS/MS for the rapid determination of enrofloxacin and
ciprofloxacin in edible tissues [167]. Tissue samples (bovine, porcine, turkey, rabbit)
were extracted with ACN:H2O:formic acid, filtered and an aliquot injected onto the
TFC-MS/MS system. The HTLC column consisted of a Cyclone (50 µm) styrene-
divi nylbenzene copolymer. The run time for the analysis was 4 min. The LOQ of the
method was 25 µg kg-1 in all matrices. The recovery of the method ranged between
72 and 105%.
4.6.3 96-well technology
96-well SPE was developed by researchers at Pfizers in the early 1990s to increase
sample throughput in clinical analysis [168]. The technique allows the simultaneous
extraction of up to 96 samples and reduces the sample preparation time drastically. It
furthermore reduces handling errors and limits labour input. This technique can also
be automated to improve precision and accuracy. Rubies et al. developed a 96-well
Oasis HLB SPE method for isolating nine quinolone residues from bovine muscle
prior to LC-MS/MS [169]. CCα values of as low as 2 µg kg-1 could be achieved for
norfloxacin. Surprisingly, the sample throughput of the method was limited to 24 test
samples per day. Pinel et al. have developed a 96-well SPE procedure on C18
chemistry to investigate the profile the 17β-estradiol 3-benzoate and 17β-nandrolone
laureate ester metabolites in calves urine [170]. Typical CCα values for analytes were
less than 0.10 µg kg-1. The same group also investigated the application of 96-well
SPE for the detection of the pesticide, fipronil in ovine plasma [171].
4.6.4 Dialysis
Dialysis in combination with trace enrichment and LC is a relatively simple on-line
sample preparation technique. Although it is not very selective, the dialysis cell is
easy to construct and the technique is very efficient at removing macromolecules that
may interfere with the subsequent separation and detection process. Commercial
systems, such as the Gilson ASTED XL, are also available for online dialysis. A
more detailed description of dialysis can be obtained through consultation of peer
reviewed literature [172-174]. Few applications have been reported in the literature
on the use of dialysis in residue analysis. The majority of these applications have
been applied to the isolation of antibiotic residues from meat [175], fish [176] and egg
[177].
5. Applications
5.1 Silbenes
Stilbenes are non-steroidal estrogenic growth promoters which are banned in the EU
for use in food producing animals. They include diethylstilbestrol, hexestrol and
dienostrol. Diethylstilbestrol can exist in two forms; cis and trans isomer. Stilbenes
are often analysed in conjunction with other steroids. Stilbenes are partially protein-
bound and require a hydrolysis step in order to achieve high extractability [178]. In
urine, stilbenes are present as conjugates (mainly as glucuronic acid form) [179].
Xu et al. developed a method for isolating stilbenes from animal tissues using
automated SPE on silica [178]. Enzymatic hydrolysis was found to be necessary to
achieve high recovery and good sensitivity, and resulted in a 30% increase in peak
areas. Bagnati et al. developed an IAC method for isolating stilbenes from urine and
plasma [180]. Samples were applied directly to the IAC columns and subsequently
derivatised prior to analysis by GC-MS. Dickson et al. developed a screening method
capable of identifying dienostrol and hexestrol from bovine urine using IAC and GC-
MS detection [181]. Urine samples were divided into two test portions which were
processed separately for stilbenes and zeranol. The urine samples were applied
directly to the IAC columns, which could be used up to 10 times before being
discarded. Msagati et al. developed a supported liquid membrane (SLM) method for
the isolation of stilbenes from bovine kidney, liver, urine and milk [182]. Schmidt et
al. developed a method for isolating three stilbenes and six resorcyclic acid lactones
from bovine urine [183]. After enzymatic hydrolysis, the pH of the samples was
adjusted to pH 9: stilbenes contain a phenolic hydroxyl group which provides a stable
anion at high pH. Extraction was carried by LLE and purification was performed by
SPE.
5.2 Thyreostats
Thyreostats (TSs) have been banned for use in animal husbandry in the EU since 1981
(Council Directive 81/602/EC) due to their use as growth promoting agents and their
potential teratogenic and carcinogenic effects. They act by inhibiting the production
of hormones in the thyroid gland, which results in weight gain caused by the increased
filling of the gastro-intestinal tract and the retention of H2O in edible tissues [185].
TSs are amphoteric, highly polar, low molecular weight molecules that are known to
undergo rapid tautomerisation and oxidation, which makes them difficult isolate and
analyse by MS. 4(6)-R-2-thiouracil, tapazole and 2-mercaptobenzimidazole are the
most powerful TS agents and therefore of most interest. However, naturally occurring
sulphur compounds also exhibit TS action, namely the thiocynates and oxazolidine-2-
thiones. The EU has set a MRPL of 100 µg kg-1 for all TS residues. Van den
Bussche et al. recently published a review paper on TSs that covers their analysis over
the past 35 years and is a must-read for anyone who wants to better understand the
area [185]. Mercurated affinity columns were widely used for the clean-up of
extracts, although samples are now purified using conventional SPE.
Pinel et al. were able to isolate seven TS residues from various biological matrices,
including urine, muscle, liver, thyroid, animal feed, faeces and hair [186]. Solid
samples were freeze-dried, extracted with MeOH and evaporated. Urine and solid
samples were diluted with buffer and derivatised. The sample was adjusted to pH 2-3
using HCl (3 5%) and extracted with diethyl ether. Extracts were dried over Na2SO4
and evaporated to dryness. Sample clean-up for all matrices was carried out by
reconstituting the samples in DCM, adding cyclohexane and performing SPE clean-up
with silica cartridges. TS residues were eluted with hexane/EtOAc (40:60, v/v) and
evaporated to dryness prior to reconstitution with mobile phase. Tissue and feed
required an additional reversed-phase SPE step prior to silica cartridge clean-up.
Abuin et al. later developed a simple UPLC-MS/MS method capable of detecting six
TSs in thyroid tissue [187]. Samples were extracted with MeOH, evaporated and
reconstituted in DCM/cyclohexane. Clean-up was performed on silica SPE
cartridges. This sample preparation method is easier and faster than other methods
and avoids the derivatisation step, while UPLC reduces analysis time.
5.3 Synthetic steroids and resorcyclic acid lactones
In general, steroid hormones can be divided into three principal groups; estrogens,
gestagens and androgens (EGAs). Estrogens are so called because of the important
role they play in the estrous cycle, 17 beta-estradiol is the most active of these
compounds, its synthetic equivalent is ethinylestradiol. Resorcyclic acid lactones
(zeranol and taleranol) are structurally similar to estradiol and exhibit estrogenic
effects also and have been used in animal fattening. Directive 81/206/EEC prohibited
within the EU the use of certain substances having an hormonal action (testosterone,
progesterone, melengestrol acetate, zeranol, trenbolone acetate and 17 beta estradiol)
[190]. Further to this Council Directive 96/22/EC prohibits in animal husbandry the
administration of substances having thyreostatic, estrogenic, androgenic or gestagenic
effects [191]. The EU treats all the above mentioned substances as Group A
substances hence there is a zero tolerance policy adopted: regardless of level, no
concentration is permitted in the matrices tested. Steroid compounds are difficult to
analyse due to the broad range of substances, the complexity of the matrices and the
low levels that must be reached. As a result, it is not possible to have a very specific
extraction technique. MeOH is the most widely used solvent for extraction of steroids
from tissue samples.
Impens et al. described a procedure for isolating 26 EGAs from muscle and kidney fat
with GC-MS/MS detection [192]. Samples were extracted with a mixture of NaAc :
MeOH and defatted with n-hexane, prior to partitioning into diethyl ether and silica
and NH2 SPE purification. Blasco et al. extracted 22 EGAs from bovine and porcine
muscle using MeOH. However method development activities in this study indicated
that CAN was a more selective extraction solvent [193]. In urine, steroids can be
present in free, glucuronic acid and sulphate forms, which necessitates the inclusion
of enzymatic hydrolysis to liberate conjugates. Shao et al. reports that the portion of
cleavable conjugated forms of steroids in tissue are very low, which calls into
question the requirement for a deconjugation step [194]. Impens et al. reported a
method for 22 EGAs in urine, based on simple dilution with H2O, adjustment to pH 7
and C18 SPE [195]. Subsequently, hydrolysis was carried out by incubation with
abalone acetone powder and further clean-up on amino SPE cartridges. Helix
Pomatia is widely used to deconjugate both glucuronide and sulphate forms of
steroidal compounds. However, some problems have been noted with its use,
especially conversion of steroids into other forms because Helix Pomatia possesses
oxidoreductase enzyme activity, capable of converting the steroid 3-ol group to a 3-
oxo group through oxidation [196]. Also the method is prone to interferences arising
from the chromatography step [197].
More advanced techniques for the extraction of EGAs from matrices of animal origin
have been reported but these are far less common than the classical techniques
previously described. Hooijerink et al. described a method for isolating six gestagens
from kidney fat using accelerated solvent extraction (ASE) [198]. Huopalathi et al.
extracted seven steroids from bovine tissue samples using supercritical carbon dioxide
[199]. Stolker et al. extrated 13 residues from bovine muscle, skin and fat using
unmodified supercritical CO2 and in-line alumina trapping [200]. Surprisingly few
applications have been reported in literature for isolating steroids from serum/plasma.
In this area, LLE followed by SPE is widely applied. Ferretti et al. extracted both
alpha and beta oestradiol from bovine serum with acetate buffer prior to C18 SPE
clean-up [201]. Biddle et al. developed a method for isolating estrogens from serum,
prior to GC-MS/MS [202]. Samples were deconjugated and acylated in one-step
derivatisation with 2,3,4,5,6-pentafluorobenzoylchloride (PFB). Samples were then
partitioned with ACN and dried on Na2SO4 columns. Fedeniuk et al. developed a
method for isolating trenbolone and estradiol from bovine serum prior to GC-MS
[203]. Residues were extracted from serum by LL E with 1-chlorobutane and purified
on Bond-Elut silica SPE. Draisci et al. extracted five steroids from serum with acetate
buffer and purified extracts on C18 SPE [204].
5.4 β-agonists
There are several review papers available outlining the extraction and purification
techniques used in β-agonist (βA) analysis [210-212]. Target samples for residue
analysis include edible tissues, plasma and urine, but also include retina and hair. βAs
are divided into two groups: the substituted anilines, including clenbuterol, and the
substituted phenols, which include salbutamol. It is necessary to carry out enzymatic
or acid hydrolysis of the substituted phenols as they contain conjugated esters,
particularly in the form of glucuronides and sulphates [210]. Solvent extraction
generally offers good recovery of the substituted anilines but not for the more polar
substituted phenols. Adjusting the sample pH to a higher value (usually >9) may be
necessary to obtain good recovery of the anilines. However, at high pH significant
losses may occur with the phenols, but the use of an ion-pairing reagent can help to
overcome this [211]. A range of clean-up procedures can be used to isolate residues
including LLP, IAC and MSPD. SPE is the most widely used technique with reversed
phase and mixed-mode sorbents.
Moragues et al. developed a method capable of isolating seven βAs from animal liver
and urine using a C18 SPE clean-up [213]. Fesser et al. developed a method to isolate
12 βAs from liver and retina after protease digestion [33]. Sample extracts were
purified on Oasis HLB SPE. A number of mixed mode clean-up procedures have
been developed to isolate β-agonist residues. Nielen et al. developed a generic
method capable of isolating 22 βAs using Bond Elut mixed-mode [214]. Extraction
of urine samples was carried out by enzymatic deconjugation with arylsulphatase/β-
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glucuronidase and NaOAc buffer (pH 4.8). Extraction of feed samples involved an
acid hydrolysis step (phosphoric acid/MeOH), shaking and the addition of NaOAc
buffer to an aliquot of the supernatant. Hair samples were digested with NaOH and
later neutralised with 1 M HCl and NaOAc buffer. Williams et al. developed a
method for isolating nine βAs from bovine liver and retina [32]. Extracts were
purified to mixed-mode HCX 96-well SPE cartridges, which combine strong cation
exchange and C8 reversed phase interactions. Retina samples contained fewer
interfering peaks and less ion suppression, which resulted in lower LOQs compared to
the liver samples.
MIPs has found widespread application in the βA from bovine muscle [215] and urine
[216]. Fiori et al. evaluated M I P and non-endcapped C18 SPE columns for the
isolation of eight βAs from calves‘ urine, with a special focus on minimizing ion
suppression [107]. C18 SPE achieved better overall recovery (71 -82%), but suffered
from matrix enhancement effects (1.59-2.47%). MIPs had lower recovery (29-63%)
but also had much lower matrix interferents (0.23-1.00%). In addition, there was a
progressive loss in MS signal intensity for the C18 extracts, due to a build-up of matrix
on the ESI interface. Wang et al. developed an on-line MIPs method for the selective
isolation of ractopamine in pork [217].
A number of more simple procedures have been prepared for isolating βA residues
prior to screening analysis. Haughey et al. developed a biosensor-based assay for
isolating clenbuterol from bovine urine [218]. Samples extracted with NaOH/MTBE,
frozen using an aluminium block precooled in liquid nitrogen and the MTBE layer
way carried through to analysis. Other groups have developed screening procedures
based on LLE [219] and/or SPE [220,221]. Haasnoot et al. developed a novel
immunofiltration sample clean-up for isolation of 10 βAs from urine [141]. Urine
samples were mixed with polyclonal antibodies raised against salbutamol and isolated
by ultra-filtration. The antibody bound βAs were freed from the antibodies by
washing with MeOH/0.1 M HAc and analysed by ELISA. The LOD was 30 times
lower than that achieved with urine applied directly to the ELISA.
5.6 Nitrofurans
The amphenicol class of antibiotics consist of chloramphenicol (CAP), thiamphenicol
(TAP), and florfenicol (FF). While CAP is included in annex IV of Council
Regulation 2377/90 (banned substance), TAP and FF are approved for use in all food
producing species. Once administered, FF is rapidly metabolized to the more
persistent florfenicol amine (FFA). The marker residue of FF is described as the sum
of FF and its metabolites measured as FFA [28]. Amphenicols are generally analysed
in multi-residue methods and numerous papers have been published for their analysis
in food. Zhang et al. developed a method for the isolation of FF and FFA in fish,
shrimp and pig muscle based on Oasis MCX clean-up [225]. Zhang et al. latered
extended the scope of the method to four amphenicols in chicken muscle [226]. Shen
et al. developed a method to isolate CAP, TAP, FF and FFA in poultry and porcine
muscle and liver based on Oasis HLB clean-up after EtOAc extraction at alkaline pH
[227]. This group introduced a -20°C incubation step to removed lipids.
Van de Riet et al. also developed a simple method to isolate the four amphenicols
from aquatic species based acetone extraction and LLP clean-up [228]. Boyd et al.
used MIPs to selectively isolate CAP in honey, urine, milk and plasma [229].
Isolation of CAP in honey was compared with MIPs, HLB SPE and LLE. By
performing a total ion scan the cleanliness of the extracts were determined. MIPs
displayed superior sample clean-up compared to LLE and SPE, as there were fewer
interference mass ions in the scan. Ion-suppression effects were also investigated and
the MIP extracts displayed minor ion-suppression effects compared to LLE and SPE.
A number of screening assays have been developed to isolate amphenicol residues.
Shakila et al. developed a microbial screening assay for the detection of CAP in
shrimp after extraction with with EtOAc/NH4OH and ACN [230]. Luo et al.
developed an ELISA method for screening FF residues in fish feed [231]. Sample
were extracted with EtOAc, concentrated and purified by simple LLP. The method
was later adapted to swine muscle [232]. Huang et al. carried out enzymatic digestion
to isolate conjugated CAP residues in carp serum and muscle [233]. The results of
this study showed the need to carry out enzymatic or chemical hydrolysis prior to
extraction. However, metabolism of CAP varies between species with the conjugated
CAP present in pigs but free residues present in cattle and chickens.
Nitrofuran (NF) residues have been banned in the EU since the late 1990s due to their
carcinogenic and mutagenic properties. In the early 2000s, methodologies were
developed that allowed more effective monitoring of NF residues. The analysis of NF
residues has recently been reviewed in detail by Vass et al. [47]. Two approaches can
be adopted in NF analysis, namely, extraction of total (free and bound) or bound
residues. The total residue approach has been applied by several groups and offers
advantages in terms of speed as it eliminates the need for time-consuming washing of
tissue [242-247]. NF metabolites (AHD, AOZ, AMOZ and SEM) are usually released
from tissue by acid hydrolysis and derivatised (overnight incubation with HCl and 2-
nitrobenzaldehyde (NBA)). After neutralization, tissue extracts are typically extracted
with EtOAc and undergo solid phase extraction prior to determination by LC-MS/MS.
A particular disadvantage of analysing total NF residues is that lower sensitivity can
be achieved due to matrix effects.
As an alternative, the bound residue approach can be adopted. This involves the
labour intensive washing of tissues to remove free residues and matrix components
but produces a cleaner extract [50,248,249]. This approach is used to confirm the
presence of NF residues in samples because total residues are now widely considered
to be insufficiently specific to identify illegal use of NF residues, especially in the
case of nitrofurazone abuse (monitoring of the SEM metabolite). Samples are
disrupted in the presence of MeOH:H2O followed by subsequent washings with ice-
cold MeOH, EtOH and diethyl ether. Diethyl ether is allowed to evaporate overnight
and the sample pellet is hydrolysed, derivatised and neutralized prior to extraction
with EtOAc. A disadvantage of this protocol is that an extra day is required to allow
evaporation of the diethyl ether, which increases sample turnaround time. Verdon et
al. developed an alternative approach for the determination of bound residues based
on two MeOH:H2O (50:50 and 75:25, v/v) washes followed by a pure MeOH and a
pure H2O wash [247]. The advantage of this approach is that the sample pellet can
proceed to the hydrolytic derivatisation step on the same day as washing, reducing
assay time by one day.
Recent improvements have been made in NF analysis in honey and milk. Honey is
particularly challenging because matrix components interfere with the derivatisation
process and result in a lower yield of NF derivatives. Several groups have highlighted
the need to include an SPE clean-up to ensure good yield of the derivatives [250-252].
Jenkins and Young dissolved honey samples in 0.12M HCl (30°C for 30 min) prior to
purification on Oasis HLB cartridges [251]. It was proposed that this step removed
interfering compounds such as polyphenolic constituents, waxes and organic
contaminants. The purified extract containing NF metabolites and sugars was
subsequently derivatised overnight with NBA and purified on a second Oasis HLB
cartridge prior to analysis. Lopez et al. recently developed an improved method for
isolating NFs from honey based on the Jenkins and Young method [252]. Honey
samples were dissolved in 10% NaCl instead of 0.1 2M HCl prior to HLB purification.
This approach gave higher absolute recoveries than those obtained when the sample
was dissolved in 0.1 2M HCl. After derivatisation and pH adjustment, NaCl was
added to samples to reduce emulsion formation and enhance the partitioning of NF
residues into the EtOAc phase. A hexane wash step was included to remove bee wax
and unreacted NBA. This group found that the second HLB SPE step was
unnecessary and NF residues could be successfully isolated with EtOAc. Groups
have recently reported methods to isolate NF residues from milk [253,254]. Chu et al.
derivatised whole milk samples and defatted them with hexane prior to HLB SPE
[253]. Rodziewicz et al. developed a simple procedure to isolate NF residues from
defatted milk samples [254]. Samples were derivatised and subsequently extracted
with EtOAc prior to analysis.
One of the major obstacles for NF analysis is the identification of a suitable marker
residue for nitrofurazone abuse. The suitability of SEM as a definitive marker for
nitrofurazone misuse has been questioned in light of the discovery that SEM in food
may arise from sources (azodicarbonamide and carrageenan) other than this illegal
veterinary antibiotic. In response to this problem, Cooper and Kennedy investigated
retina as an alternative matrix for verification of NF abuse [36]. This group found
that total NF antibiotic metabolites could be detected at mg kg-1 levels in the retina of
pigs due to the accumulation of drug residues in the eye. It was proposed that retinal
analysis may allow detection of NF abuse in animals at any point from birth to
slaughter. Cooper et al. also investigated the metabolism of NFs in chicken and found
that the intact nitrofuran parent compounds could be detected in the eyes of treated
birds [255]. A major advantage of retinal analysis comes from the high
concentrations of NFs that can occur in the retina which allows samples to be
analysed by HPLC rather than LC-MS/MS.
5.7 Nitroimidazoles
Nitroimidazoles are imidazole heterocycles with a nitrogen group incorporated in the
structure. They can be used for the prophylactic and therapeutic treatments of
diseases such as histominiasis and coccidiosis in poultry, genital tricchoniasis in cattle
and hemorrhagic enteritis in pigs. These compounds are metabolised extensively in
bovine, porcine and avian species [256] and the main metabolism route is through
oxidation of the side chain on the C-2 position of the imidazole ring to form hydroxy
metabolites. Although ronidazole has a different degradation pathway than
dimetrimadazole, they form an identical metabolite [256]. Nitroimidazoles are
believed to be carcinogenic and mutagenic to humans [257-259] and as a consequence
were banned for the use in food producing animals within the European Union under
Regulation 2377/90 [28]. Previously the analysis of these compounds was carried out
in liver and muscle [260,261] but studies on the stability and homogeneity of
nitroimidazoles in incurred muscle [262,263] show that there is not a homogenous
distribution of analyte in turkey muscle and also there is a rapid reduction in analyte
concentration in muscle stored for prolonged periods above 4°C. In contrast,
nitroimidazole residues are stable in plasma, retina and egg matrices. As a result,
plasma, retina and egg have been recommended as target matrices for the residue
control of nitroimidazoles [262,263].
A number of methods have been developed to isolate nitroimidazole residues from
egg, most based on ACN extraction [256,260,264,265]. Two groups found that after
extraction no additional purification was necessary [260,265]. Other groups have
found that addition of NaCl and SPE clean-up on Oasis HLB or MIPs was required
[256,264]. Many methods exist for the determination of nitroimidazoles in tissue
samples [260,266-268]. Polzer et al. developed a method to isolate seven
nitroimidazoles from poultry and porcine muscle based on enzymatic hydrolysis
followed by purification on kieselguhr SPE cartridges [261]. Xia et al. developed an
interesting method that allowed the simultaneous isolation of nitroimidazoles as well
as a number of nitrofurans in porcine muscle [269]. A number of groups have
developed screening methods to detect nitroimidazole residues based on HPLC-UV
[112] and immunobiosensor detection [270]. Han-Wen Sun et al. reported a sensitive
HPLC-UV screening method capable of detecting seven nitroimidazoles in porcine
and poultry muscle to <0.8 μg kg-1 [112]. Fraselle et al. developed a method to detect
seven nitroimidazoles in porcine plasma using NaCl/potassium phosphate buffer and
protease solution [271]. Digested samples were purified by SPE. Cronly et al.
reported a simple method to isolate 10 nitroimidazole residues from serum [272].
Samples are extracted with a mixture of NaCl and ACN and subsequently defatted
with hexane.
5.8 Antibiotics
5.8.1 Aminoglycosides
Aminoglycoside (AMG) residues are basic residues that are soluble in aqueous
solvent but are poorly soluble in organic solvent. It has reported that AMG residues
are difficult to extract from tissue due to tight binding to proteins and require release
by aqueous solution containing strong acid or bases [5]. In recent years, extraction
with trichloroacetic acid and subsequent purification on SCX has found widespread
application. However, this approach results in low recovery of some residues such as
streptomycin because of strong retention on the SCX. Alternative methods have been
proposed for the purification of extracts based on MSPD, WCX and ion-pair
chromatography [83,114,276]. Recent developments suggest that it is possible to
isolate the most important aminoglycoside residues from biological tissues using a
single extraction procedure and clean-up on multiple SPE cartridges [114]. The
methods have improved significantly but still do not include some residues such as
framycetin. In total, from the methods described there are a total of 14 target drugs,
with 16 residues if the isomers of gentamicin are included.
Bogialli et al. developed an MSPD method for isolating nine AMG residues from
milk based on dispersion on Na2EDTA-treated sand and hot H2O extraction at 70°C
[83]. Kaufmann and Maden give an excellent report on the development of a WCX
method that delivers adequate recovery of streptomycin and 11 other residues from
liver, meat and fish prior to LC-MS/MS analyses [276]. Zhu et al. developed a simple
method for isolating 13 AMG residues from muscle, liver and kidney based on
extraction with 5% TCA and ion pair SPE [114].
5.8.2 β-lactams
-lactams (βLs) represent a broad class of antibiotics, the most significant of which are
the cephalosporins and penicillins. These compounds are typically H2O-soluble, but are
degraded by extremes of pH and elevated temperature. In addition, the - lactam ring
structure itself can readily undergo methanolysis, breaking the ring and leading to the
formation of methyl ester or penicilloic acids. As a result, MeOH is an unsuitable solvent
for extraction and/or analysis of βLs. Consumer MRLs have been laid down for these
substances under EU regulation 2377/90 [28]. Issues pertaining to the lack of stability
in milk and tissues of certain βLs has been reported in literature [39]. The degradation
products of two cephalosporins, ceftiofur and cephapirin, in kidney extract and in acidic
and basic solutions was described in recent work by Berendsen et al. [277].
A number of groups have reported the extraction of βLs from milk [278]. Mastovska and
Lightfield reported a method for isolating 11 βL antibiotics from bovine kidney based on
ACN:H2O extraction DSPE clean-up on C18 [279]. The authors highlighted that extracts
should not be diluted in solutions containing formic
acid because they observed rapid degradation of penicillin G and nafcillin. The group
report lower recovery for desfuroylceftiofur cysteine disulfide (DCCD), a metabolite
of ceftiofur. Other groups have developed direct injection methods for analysing βLs
[280,281]. Ito et al. found that significant improvements in sensitivity could be achieved
through application of ion-exchange clean-up for isolating penicillins from bovine liver.
Katiani et al. developed an on-line SPE method for measurement of sub-ppb levels of
βLs in milk by LC-MS/MS [160]. However, the authors noted that matrix effects were
evident, leading to ion suppression ranging from 5 to 75%. Oliveira and Cass exploited
restricted access media (RAM) columns to separate cepaholsporin residues from milk
[282]. Becker et al. developed a comprehensive method for isolating 15 βLs from bovine
muscle, kidney and milk prior to LC-MS/MS analysis [283]. Samples were extracted with
ACN:H2O and purified on Oasis HLB cartridge. Daeseleire et al. extracted 11 βLs from
milk with ACN and analysed samples without purification by LC-MS/MS [284].
Bruggeman et al. showed that an appropriately imprinted polymer matrix could be used
to separate oxacillin from other
penicillin compounds in a mixture [285], which highlights the potential of this
separation technology.
5.8.3 Macrolides and lincosamides
Macrolides and lincosamides are two classes of antibiotic with similar antibacterial
activity, but differing in chemical structure [5]. The macrolides may be described as
being multi-membered lactone rings with one or more sugar moieties attached; the
most commonly used members of this compound class are erythromycin and tylosin.
The lincosamide antibiotics consist of lincomycin and semi-synthetic derivatives
thereof, such as clindamycin and pirlimycin. The structure of lincomycin itself is of a
five-membered cyclic amino amide, attached to a thioglycoside side-chain. Both
classes of compound are used primarily in food-producing animals for the treatment
of bacterial infections, such as mastitis [289]. The broad range of chemical
functionalities associated with these compounds can thus pose a challenge to sample
preparation. Macrolides are soluble in MeOH, and with isolated or conjugated double
bonds, exhibit a somewhat hydrophobic profile. They are unstable in acid, and are
typically extracted from alkalinised matrices [290]. Both classes of compound have
been extracted using MeOH, aqueous buffer, ACN, or mixtures of ACN and aqueous
buffer [291]. A number of sample preparation methods for the isolation of macrolides
in food matrices have been reported, as described by Wang in a comprehensive
review on analysis of macrolides in samples of food, biological and environmental
origin [292]. A range of methods have been developed for the isolation of macrolides
and lincosamides using SPE, LLE, direct injection (―dilute and shoot‖) and matrix-
assisted solid phase dispersion samples preparation approaches.
There has been particular interest in detecting macrolide antibiotic residues in honey
in recent years. Benetti et al. extracted five macrolides and lincomycin from honey
with tris buffer and purified extracts on Oasis HLB prior to LC-MS/MS [293].
Thompson et al. investigated the fate of tylosin residues in the honey from treated
bees [294]. This study showed that tylosin A degrades to yield the antimicrobially
active degradation product tylosin B, also known as desmycosin. Wang and Leung
later developed a method to detect the residues of seven macrolide residues (including
Tylosin B) in eggs, honey and milk prior to LC-MS/MS [295].
A number of methods have been developed for detecting macrolide residues in animal
tissue and fish. Bogialli et al. developed a method for hot H2O extraction isolating six
macrolides from milk and yogurt dispersed on sand [85]. Berrada et al. evaluated the
suitability of EDTA-McIlvaine buffer and PLE for isolating macrolides from liver and
kidney [296,297]. Horie et al. extracted nine ML residues from meat and fish with
0.2% metaphosphoric acid:MeOH (6:4, v/v, 100 mL) [298]. Martos et al. developed a
method to measure nine macrolides in animal tissues [299]. Samples were extracted
ACN, diluted with H2O and defatted with hexane prior to LC-MS/MS. This is an
interesting application because it contains all three lincosamides. The method
developed by Kaufmann is probably the most comprehensive to date because it
includes 18 different macrolides and lincosamides [15]; although the total number of
macrolides and lincosamides that have been analysed in food in different peer
reviewed papers approaches 30 compounds. However, many of these are probably
not widely used as veterinary drugs.
5.8.4 Quinolones
Quinolones are antibacterials used for the treatment of infections in both human and
veterinary medicine [301]. Their structure consists of an eight-membered
heterocyclic system bearing one aromatic ring, a carboxylic acid and a ketone.
Modifications to improve antibacterial activity and selectivity have been made,
including introduction of fluoro- groups, as well as alkyl and aryl groups. The range
of substituents, configurations and chemical properties which quinolones may contain
possess challenges to the development of multi-residue methods and the sample
preparation steps associated with these compounds must be optimised extensively
[302].
Conventional procedures for the isolation of quinolone residues are normally based on
solvent extraction with H2O, acidic aqueous or polar organic solvents (MeOH or
ACN). Samples are normally purified on bonded silica or polymer-based SPE phases.
Jiménez-Lozano et al. compared seven different kinds of SPE sorbent, including
Zorbax C18, Bond Elut C18, Isolute ENV+, Oasis HLB, Oasis MAX, SDB-RPS, and MPC-
SD, for the isolation of eight quinolones from animal tissue [303]. The superior
performance of the polymer-based sorbents was highlighted. Best results were
obtained using SDB-RPS and Oasis MAX cartridges. Similar recovery was observed
for all quinolones on both polymeric sorbents, with the exception of ciprofloxacin
which was best recovered on an Oasis HLB cartridge (87%). Christodoulou et al.
extracted 10 quinolones from various tissues with 0.1% TFA in MeOH prior to C18
SPE clean-up [304]. Christodoulou et al. in the same paper evaluated the suitability
of different SPE sorbents including silica and polymeric (DSC- 18, a LiChroLutRP- 18,
an Adsorbex C8 and Abselut NEXUS). LiChroLut RP-18 showed highest analyte
recovery, followed closely by Abselut NEXUS.
Zhang et al. analysed 22 quinolones in bovine milk using UPLC-MS/MS as the
detection system [305]. Samples were extracted with EDTA-McIlvaine buffer (2 x 10
mL) and the supernatant was applied to a pre-conditioned BondElut Plexa SPE
cartridge, which is designed to minimise retention of proteins on the surface of the
polymer stationary phase. The quinolones were then eluted with MeOH, the extract
was evaporated and reconstituted in 2 mL of mobile phase. Toussaint et al. developed
a method for isolating 11 quinolones from pig kidney [306]. Other groups have
developed methods for isolating quinolone residues from animal tissues [307]. More
novel methods have also been developed including hot water extraction [87]. An
effective alternative to quinolone pre-concentration via conventional SPE bonded
phases is described by Li et al. [122]. Using an immunoaffinity column the group
successfully developed a method to isolate 13 quinolones and six SAs in swine and
chicken muscle. Zhao and Li et al. used the same method to isolate 10 quinolones in
chicken muscle but used HPLC-FL for analysis [123]. The authors note the
possibility of greater selectivity when using such IA columns, compared with the
smaller range of interaction mechanisms available for exploitation with more
conventional SPE formats.
5.8.5 Sulphonamides
Sulphonamides (SAs) are amphoteric molecules containing different pKa values.
They are poorly soluble in H2O and non-polar solvents, but readily soluble in polar
organic solvents. Extraction is typically carried out with DCM, acetone, EtOAc or
ACN. The most widely used isolation method for SAs involves LLE followed by
SPE clean-up. When extracting SAs from an organic phase into an aqueous phase, it
is important to adjust the pH of the aqueous phase to obtain high recovery [10]. This
is due to SAs ionic nature, which is caused by the inductive effect of the SO2 group
[316]. Between pH 5.0 and 5.2 the commonly used SAs are uncharged. The MRL
for SAs is reported for muscle, fat, liver, kidney and milk, although other matrices are
frequently also analysed (bile, urine and blood serum). The MRL is expressed as the
sum of the parent drugs and the combined residues of all substances in the
sulphonamide group should not exceed 100 µg kg-1. Hence, it is critical to have
methods that are capable of isolating a wide range of SAs. Many sulfonamide
formulations are supplied as combination products having two main components, a
sulfonamide and a diaminopyrimidine (e.g. trimethoprim and ormethoprim) [317].
These combinations are believed to act synergistically on specific targets in bacterial
DNA synthesis. Hence, it is common to analyse diaminopoyrimidines together with
SA [276-281]. Recent review papers by Wang et al. [10] and Samanidou et al. [318]
provide an excellent overview of SAs in foodstuff of animal origin. The authors
discuss the chemistry, antimicrobial activity, legislation and provide a comprehensive
review of published methods.
Cai et al. extracted 24 SA residues from muscle with ACN, defatted with hexane and
partitioned with H2O and EtOAc prior to UPLC-MS/MS [319]. Di Sabatino et al.
isolated 10 SAs from meat samples using LLE and cation-exchange SPE purification
[320]. Gamba et al. used a similar procedure to isolate seven SAs from milk [321].
Forti et al. isolated 10 SAs in egg by extracting with a mixture of acidified (HAc)
DCM/acetone and purification on cation-exchange SPE cartridge [322]. Farooq et al.
extracted SAs from meat using an ACN/1-propanol solvent system [323]. Sample
extracts were purified on Cleanert PEP-SPE cartridges prior to analysis by capillary
zone electrophoresis Zou et al. developed a method capable of isolating 12 SAs from
animal tissues [324]. Zou et al. used the same derivatisation procedure to determine
eight SAs from honey [325]. However, extraction was carried out by MSPD using
C18 as the dispersant. Sergi et al. developed an MSPD method to isolate 13 SAs from
bovine muscle and meat containing baby food using C18 as dispersant and chilled
MeOH (0°C) as eluting solvent [326]. Li et al. developed an IAC method capable of
isolating nine SAs from chicken tissues [327]. Van Rhijn et al. developed a simple
ultra-filtration method capable of isolating six SA residues in milk [19]. Samples
were mixed with ACN to precipitate proteins and solubilise the SA residues. After
ultra-filtration, the extracts were analysed by LC-MS/MS. Koesukwiwat et al.
developed a method for the simultaneous isolation of six SAs, three tetracyclines and
pyrimethamine in milk [328].
5.8.6 Tetracyclines
The tetracyclines (TCs) are broad spectrum antibiotics and some of the most widely
used veterinary drugs in animal husbandry [334]. Members of the TC group have
similar chemical and physico-chemical properties, and are soluble in acids, bases and
polar organic solvents (particular alcohols), but insoluble in saturated hydrocarbons.
They are amphoteric molecules and only achieve a neutral state as zwitterions. TCs
are prone to degradation under strongly acidic and alkaline conditions where they
form reversible epimers, namely 4-epi-TCs, anhydro-TCs and iso-TCs. MRLs are
established based on the sum of the parent compound and 4-epimer. TCs form
chelation complexes with multivalent cations and bind with proteins and silanol
groups [335]. Aqueous-based extraction is the primary extraction system for
tetracyclines. EDTA is widely used in aqueous extraction and pre-treatment of C18
SPE cartridges to minimise TCs interaction with chelating complexes or adsorption
onto free silanol groups. Deproteination is normally carried out under mildly acidic
conditions using HCl, trichloroacertic or phosphoric acids. LLE from an aqueous
phase into an organic phase is difficult to perform due to TCs charge and low affinity
for organic solvents. However, ion-pairing reagents can be used to transfer TCs into
the organic phase.
Polymeric SPE cartridges have found widespread application in tetracycline analysis
in recent years. Pena et al. isolated TC, OTC and CTC residues from porcine tissues
using EDTA-McIlvaine buffer (pH 4) [336]. Extracts were deproteinated with 20%
TCA and purified on Oasis HLB cartridges. Similar approaches have been adopted
by other groups to isolate TCs from milk [337,338]. Nikolaidou et al. developed a
method capable of isolating seven TCs from bovine and porcine muscle based on
extraction with oxalate buffer (pH 4) prior to purification on Nexus SPE [339]. The
same group developed a similar method to isolate seven TCs from bovine liver and
kidney [334]. Samples were extracted with 0.4M oxalate buffer (pH 4) and 20% TCA
and purified on Discovery (kidney) and LiChrolut (liver) SPE cartridges.
Li et al. developed a simple automated SPE method for on-line extraction of five TCs
from honey [340]. The honey samples were diluted in 0.1 M Na2EDTA-McIlvaine
buffer (pH 4) filtered prior to on-line SPE on a C18 column. Bogialli et al. developed
a simple MSPD method for isolating four TC residues (TC, OTC, CTC, DC) and 3 of
their 4-epimers from bovine, porcine and poultry muscle [84]. MSPD was performed
with Na2EDTA treated crystobalite and hot H2O extraction at 70°C. Some groups
have investigated the suitability of MIPs for isolation of TC residues from kidney
[341] and animal tissue [342]. Jing et al. encountered difficulties when isolating TC
residues from egg and required an alternative MSPD procedure [342]. Bogialli et al.
also found that MSPD combined with a hot water extraction was a suitable technique
for isolating TCs from muscle tissue [84]. Blasco et al. developed a more automated
hot water extraction on an ASETM system [343]. Other groups have developed more
novel clean-up procedures using dispersive SPME [344] and metal chelate affinity
chromatography (MCAC) [345].
5.9 Anthelmintics
Anthelmintic drugs are used to treat parasitic infections and include benzimidazoles
(BZs), flukicides (FCs), levamisole, macrocylic lactones (MLs), and morantel. A
number of specific methods exist for the determination of anthelmintic residues.
Danaher et al. isolated five M Ls from liver with ACN extraction prior to clean-up on
deactivated alumina and C18 [348]. Wang et al. developed a similar method but did
not carry out the C18 SPE [349]. Milk methods require greater sensitivity due to the
lower M RLs and because many drugs are not approved for use in lactating species.
Some groups have developed sensitive methods based on ACN extraction with C8 or
C18 SPE clean-up [350,351]. BZs are more difficult to extract due to the possible
presence of some 21 key residues. In addition, it is desirable to include levamisole
when testing for BZs but this necessitates LC-MS/MS detection. Dowling et al.
developed a multi-residue method for isolating 12 BZs from bovine liver [106].
Samples were extracted by LLE with EtOAc and purified by LLP and automated C18
SPE. More comprehensive LC-MS/MS methods have been developed recently.
Albin et al. isolated 22 BZs from meat with 1% formic acid and ACN without further
clean-up [352]. Radeck et al. subjected milk samples to acid hydrolysis and extracted
23 anthelmintics, including all the main BZ residues and levamisole, with ACN [353].
Extracts were defatted with hexane prior to analysis. Van Holthoon et al. extracted 17
BZs (including levamisole) from milk with ACN and extracts were purified by on-line
SPE clean-up using Oasis MAX cartridges [354]. The same groups developed a
method to isolate 24 BZs (including levamisole) from egg [20]. Extraction was
carried out with ACN and different clean-up procedures were evaluated, including
ultra-filtration, off-line SPE and on-line SPE on Oasis MAX cartridges. Ultra-
filtration was found to be the preferred extraction technique due to its ease of
operation. Few methods have been reported in the literature for the analysis of
flukicide residues and msot are mainly single residue methods. Caldow et al.
developed an LC-MS/MS assay for phenolic and salicylanilide flukicides in bovine
kidney and muscle [355]. Samples were extracted with 1% HAc in acetone and
purified on mixed-mode anion-exchange SPE. However, the method was not
sufficiently sensitive to allow reliable detection and quantification of oxyclozanide.
Kinsella et al. developed and validated a multi-class method capable to isolate 38
anthelmintic residues from bovine milk and liver based on the QuEChERS technique
[16].
5.10 Anticoccidials
Anticoccidials (or coccidiostats) are used for treating infections in a range of food
producing animals. However, they are most widely used in intensively reared animals
(poultry and pigs), followed by calves and lambs. They can be broadly described as
polyether ionophores or chemical anticoccidials. Traditionally, anticoccidials were
analysed by single residue methods using HPLC or immunochemical assays.
Gerhardt et al. developed one of the first multi-residue methods that allowed detection
of three ionophore residues (monensin, salinomycin and narasin) by HPLC with post-
column derivatisation UV [362]. Since early 2000s, LC-MS/MS has found
widespread application in the analysis of anticoccidials and has allowed the
simultaneous detection of their residues at low levels [212]. In addition, some groups
have developed assays that additionally include nitroimidazoles [363,364]. However,
the nitroimidazoles are normally analysed separately. Blanchflower and Kennedy
reported an early method to isolate three ionophore residues from tissue and eggs
[365]. Matabudul et al. dispersed egg and liver samples on anh. Na2SO4 and extracted
four ionophore residues with prior to ACN prior to silica SPE [366]. This method has
since been applied by several groups to the analysis of multiple anticoccidials residues
from egg, liver and muscle [363,367,368]. Mortier et al. developed a simple
procedure for isolating anticoccidials residues from egg samples without the need for
sample purification [364,369].
Difficulties faced in the analysis of anticoccidial residues include the detection of
amprolium, semduramicin and toltrazuril residues. Amprolium and semduramicin can
present difficulties due poor chromatographic retention and poor peak shape,
respectively. In the case of semduramicin, this problem can be offset by the exclusion
of Na2SO4 from the sample preparation process. Toltrazuril residues (particularly
toltrazuril sulphone) present a challenge because of poor response in MS compared to
other anticoccidials. As a result, few multi-residue methods have been reported in
literature for these residues. Some groups have successfully developed methods to
measure toltrazuril residues in eggs [370,371]. Hormazabal and Yndestad developed
a complex LLP method for isolating anticoccidial residues including amprolium from
tissue, plasma and egg [7]. Amprolium, ethopabate and ionophore extracts were
injected separately onto the LC-MS. Olejnik et al. recently developed a
comprehensive method for 12 anticoccidial residues from liver based on ACN
extraction with purification on neutral alumina and Oasis HLB [372]. One criticism
of this method is the exclusion of amprolium, ethopabate and toltrazuril residues.
However, the method contains the most important coccidiostat residues, which are
outlined in new legislation 2009/124/EC [373] and one can conclude that this is one
of the better anticoccidial methods reported in literature to date. Future targets in
anticoccidial analysis are the development of methods that will allow the analysis of
residues to new non-target MRLs that have been listed for eggs, milk and tissue, while
possibly simultaneously detecting nitroimidazoles residues.
5.11 Carbamates
Carbamates are a group of highly effective insecticides sharing the functional group -
NH(CO)O-. Several methods have been developed to determine carbamates in a
range of food commodities. Carbamate residues may be detected by GC-MS, HPLC
fluorescence following post-column derivatisation, or more recently LC-MS. A
particular challenge faced in the analysis of carbamate residues is their thermal
lability, which highlights the need for careful control of temperature during sample
preparation. Ali developed a multi-residue method to detect 10 carbamate residues in
liver [374]. Partially frozen liver was mixed with anh. Na2SO4 and extracted by
homogenisation in the presence of DCM prior to GPC and aminopropyl Bond Elut
SPE purification. Ali highlighted the need to carry out all evaporation steps at 30ºC
to ensure satisfactory recovery of the thermally labile carbamate residues [374].
Voorhees et al. subsequently addressed the problem of thermal lability by using on-
line SFE – supercritical fluid chromatography coupled to MS (SFC-MS) [375].
Chicken and beef muscle samples were extracted with supercritical CO2 and trapped
on 7% diol on C18, prior to detection by SFC-MS. The system offered advantages in
terms of eliminating time consuming solvent evaporation steps. However,
disadvantages of the method were that frequent clogging of the cryogenic retention
gap resulting in significant downtime and lower recovery when compared with
solvent extraction. Argauer et al. extracted carbamate residues from ACN extracts of
ground meat using SF-CO2 (329 bar, 60°C) with off-line trapping on C18 [376].
Blasco et al. isolating Pesticide residues (including five carbamates) by dissolved
honey in H2O and applying extracts to C18 SPE [377]. Zhen et al. extracted seven
carbamate and other pesticide residues from honey samples with MeOH-EtOAc [378].
Extracts were concentrated on an SPE column prepared from Florisil® and anh.
Na2SO4. Lehotay et al. evaluated the suitability of QuEChERS, traditional SPE and
MSPD for isolating 32 pesticides (including carbabryl and propoxur) from milk and
egg [63]. The QuEChERS method involved extraction with 1% HAc in ACN
followed by addition of anh. MgSO4 (6 g) and anh. NaOAc (1.5 g). Extracts were
purified over PSA and C18. SPE clean-up was carried out on C18 and PSA in series.
MSPD method, involved dispersing samples C18 and Na2SO4. Dispersed samples
were transferred to an empty SPE reservoir, which was stacked on top of a Florisil®
cartridge. Analytes were eluted with ACN and concentrated prior to analysis. The
methods were found to be comparable although some overestimation was seen using
the MSPD method, which was also more time consuming due to requirement of a
concentration step.
5.12 Pyrethroids
Pyrethroids are synthetic insecticides derived from naturally occurring pyrethrin
compounds which combine efficacy, safety, low environmental hazard and
photostability [379]. The widespread use of pyrethroids in crop protection and animal
husbandry can lead to the transfer of residues to animal tissues, milk, eggs and honey.
The majority of methods are based on fat analysis because pyrethroids residues
accumulate in this matrix [380]. Pyrethroid residues may be purified through
adsorption chromatography using Florisil® , silica or alumina, which retain the lipid
component of the samples [379]. Sun et al. described a multi-residue method to
analyse beef fat for the presence of 18 pyrethroids [381]. Fat was mixed with
deactivated Florisil® and packed into a disposable column which was then stacked
tandem with a C18 SPE column and eluted with ACN. Argauer et al. developed a
method to isolate ten pyrethroids from ground meat using SF-CO2 [382]. Rissato et
al. reported a SFE method that combined extraction and Florisil® clean up of
pyrethroids residues from honey samples [383]. More recently solid-phase
microextraction (SPME), MSPD and QuEChERS have been used in the analysis of
pyrethroids. Fernandez-Alvarez et al. developed a multi-residue method to isolate
pesticides, including pyrethroids from bovine milk based in SPME [384]. The same
group developed an MSPD method for the isolation of 32 pesticide residues, including
pyrethroids, from cattle feed using alumina blended with anh. Na2SO4. An adsorbent
(co-column); Florisil®, was packed at the bottom of the main column to offer a further
degree of fractionation and clean-up. The use of the QuEChERS technique for the
analysis of permethrins in milk and egg was described by Lehotay and Mastovska
[63]. The method involved shaking the sample in a tube with acidified ACN, anh.
MgSO4 and anh. NaOAc. Extracts were purified by DSPE using PSA, C18 and anh.
MgSO4. Stefanelli et al. used automated solvent extraction to isolate pyrethroid
residues from ground beef [385]. Beef samples were mixed with anh. Na2SO4 and sea
sand prior to extraction with light petroleum at 70°C. After H2O removal (Na2SO4),
the extract was concentrated and resuspended in hexane. SPE clean-up was
performed by a tandem-cartridge system consisting of an Extrelut NT3 (diatomaceous
earth) cartridge combined with a Sep-Pack C18 cartridge and a Florisil® mini
cartridge. The final extract was evaporated and reconstituted in isooctane.
5.13 Sedatives
Sedatives and -adrenergic receptor blockers, such as carazolol and propranolol, are
used in farming to reduce the stress levels of animals during transportation,
particularly pigs. The most frequently used sedatives include the phenothiazines
(such as chlorpromazine, acetopromazine) and butyrophenones (such as azaperone).
The use of phenothiazine sedatives is not permitted (primarily licensed for use in
companion animals) in the EU, while the MRL for carazolol in bovine or porcine
muscle has been set at 5 g kg-1 and the MRL for azaperone residues has been set at
50 g kg-1 in animal muscle (including the metabolite azaperol). Despite the varying
molecular characteristics of these compounds, multi-residue methods of analysis have
been developed.
Govaert et al. isolated five tranquilisers and the beta-blocker carazolol from pig
muscle using ACN and purified extracts on SepPak C18 [387]. Olmos-Carmona and
Hernández-Carrasquilla isolated seven tranquilisers from urine using C18 SPE cleanup
[388]. Samples required dilution in TEA to minimise residual silanol effects. Zhang
et al. investigated the suitability of silica, NH2, C18 and Oasis HLB sorbents for isolating 19
-blockers and 11 sedatives from animal tissue prior to LC-MS/MS
[389]. Satisfactory purification of ACN extracts were achieved using NH2.
Polymeric bonded stationary phases for SPE cartridges are often preferred for
sedatives due to the absence of secondary retention effects associated with free silanol
groups found on C18 bonded phases. Kaufmann and Ryser samples extracts on Oasis
HLB prior to LC-MS/MS [390]. Delahaut et al. similarly exploited Oasis HLB SPE
in their work on tranquilisers and -blockers in pig tissues [391,392]. Some
alternative methods have been developed for the isolation of these compounds other
than hydrophobic sorbents. Cerkvenik-Flaj s investigated the suitability of mixed-
mode cationic exchange sorbent (Oasis MCX SPE) for isolating azaperone and
azaperol from kidney prior to HPLC fluorescence detection [393]. Cooper et al.
extracted three phenothiazines with acidified ACN and purified extracts by LLP prior
to ELISA detection [394].
5.14 Non steroidal anti-inflammatory drugs
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a heterogeneous group of mostly
acidic drugs that can be divided into four main sub-classes: (i) salicyclic acid
derivatives (ii) propionic acid derivatives (iii) pyrazoles derivatives and (iv) aniline
derivatives, including both anthracilic and nicotinic acid derivatives. They all share
common pharmacological activity, but they are not structurally related, making
universal extraction and purification techniques difficult. Effective detection of a
range of NSA IDs may be achieved through the analysis of residues in liver or kidney,
while residues in live animals may be monitored in biological fluids and milk. In
order to get the best possible overview of the use of NSA IDs in food-producing
animals and of their residues in food of animal origin, a broad control of as many
substances of this group as possible should be aspired to. ACN is a commonly used
extraction solvent for these substances and further purification is often carried out
using SPE and or LLP. In recent years there have been a small number of multi-
residue methods which detect quite a wide range of NSA IDs. Daeseleire et al.
developed a simple method for the detection of three NSAIDs in milk based on ACN
extraction and concentration prior to LC-MS/MS [395]. Van Hoof et al. reported a
method for the determination of six NSAIDs in bovine tissue using ACN extraction
and Oasis HLB purification [396]. Metamizole (Dipyrone) is one of the few basic
NSAIDs and very few methods report the analysis of this substance in foods of animal
origin. Penney et al. reported an LC-MS/MS method for the detection of metamizole
and its marker metabolites of which 4 Methyl Amino Antipyrine (4-MAA) is the most
important in milk and muscle [397]. Samples were extracted with MeOH defatted
with hexane prior to analysis.
Malone et al. developed a method for detecting all licensed NSAIDs including 4-
MAA (and all licensed corticosteroids) in milk by LC-MS/MS [398]. Samples were
extracted with ACN and NaCl was added to aid partitioning of the milk and ACN
phase. ACN extracts were simply defatted with hexane prior to analysis. Vinci et al.
reported a method for 14 NSA IDs in plasma and serum based on protein denaturation
prior to C18 SPE purification [399]. Gallo et al. reported a method for detecting 13
NSAIDs in plasma and serum based on the previous method prior to HPLC-PDA.
Dowling et al. developed a method for the detection of four NSAIDs in milk. Milk
samples were extracted with ACN and purified on IsoluteTM C18 SPE cartridges [400].
Gallo et al. developed another method for the detection and confirmation of 16
NSAIDs in cattle and buffalo milk [401]. Milk samples were extracted using a
mixture of ACN:MeOH (90:10, v/v). Gonzalez et al. developed a LLE method to
isolating 17 NSAIDs from equine plasma and urine samples [402]. NSAIDs have
also been analysed as part of multi-class multi-residue methods. Stolker et al.
developed a method to analyse 20 NSAIDs (and other drugs) in milk using UPLC-
ToF MS [13]. Chrusch et al. developed a method to analyse 10 NSAIDs in bovine
muscle and kidney by LC-MS/MS [403]. Other groups have developed methods for
analysing NSAIDs in equine plasma and urine [404,405]. These multi-class methods
are discussed in greater detail in a later section (5.16 multi-class multi-residue
analysis).
5.15 Triphenylmethane dyes
Triphenylmethane dyes (TPMs), including malachite green (MG) and crystal
(gentian) violet (CV), are used illegally in aquaculture to treat and prevent fungal and
parasitic infections [409]. MG and CV are rapidly metabolised to their non-polar
leuco-MG (LMG) and leuco-CV (LCV) forms, which have a longer half-life in fish
than the parent compounds [410]. MG is not registered as a veterinary drug and has
potential toxicity, teratogenicity and carcinogenicity effects [411]. As a result it is not
authorised for use in animals that are produced for human consumption and the EU
has set a MRPL of 2 µg kg-1 (sum of MG and LMG) in aquaculture [412]. TPMs are
acidic molecules that are readily ionisable and suitable for ion-exchange clean-up
[413]. The non-chromophorous leuco analogues are often oxidised to their
chromophorous parent compound using PbO2 or other oxidising reagents [414]. It has
been reported that MG and LMG are rapidly degraded (most likely through
demethylation) during sample preparation [411,415].
Andersen et al. developed a method capable of isolating MG, CV, brilliant green (BG)
and leucobrilliant green (LBG) [416]. Fish samples were extracted with ammonium
acetate buffer (pH 4.5), hydroxylamine hydrochloride, p-toluene sulfonic acid and
ACN. Samples were shaken in the presence of alumina and the supernatant was
subsequently mixed with H2O and diethylene glycol. The mixture was extracted with
DCM in a separatory funnel, evaporated to dryness and reconstituted in ACN and 2,3-
dichoro-5,6-dicyanobenzoquinone (DDQ). The addition of DDQ converts leuco
compounds to their charged form which enhances sensitivity. The samples then
underwent SPE clean-up with alumina and propylsulfonic acid cartridges in series.
Jiang et al. later modified this method and applied it to the analysis of TPMs in fish
[417]. A number of groups have developed alternative methods for isolating TPM
residues using McIlvaine buffer and ACN prior to purification on aromatic sulphonic
acid [413], SAX [418] or alumina-MCX SPE sorbents [415,419]. Other groups have
used an alternative ammonium acetate and ACN extraction solvent prior to PRS
[409,420] or alumina-SCX [410] clean-ups.
5.16 Multi-class multi-residue analysis
Yamada et al. reported the first multi-class LC-MS/MS method for >100 residues in
2006 [12]. A number of other groups have followed this trend. While these methods
offer many advantages (simplicity, high sample-throughput, reduced cost) there are
compromises to be made when developing these methods (lack of specificity or
sensitivity, crude extracts that can cause problems for the detection system). These
methods may be broken into the following categories – qualitative [421] or
quantitative screening assays [15], which use ToF MS, and quantitative confirmatory
assays using LC-MS/MS. Therefore, in some cases samples may require additional
confirmatory analysis using a second technique. Another disadvantage is that while
cost per analyte is greatly reduced, the overall cost per sample is more expensive due
to the comprehensive information provided from the analysis. In the EU, there is no
advantage in applying such methods due to the present structure of European residue
control plans. One can conclude that if such methods were applied in residue
surveillance that the current number of samples tested for Group B substances could
be reduced. However, one expects that many stakeholders will request modifications
to legislation to accommodate such methodology in the future.
The main obstacle in multi-class residue analysis is the development of a generic
sample preparation step. Most multi-class methods involve simple liquid extraction
while clean-up is carried by LLP or SPE on a generic cartridge (e.g. HLB). The
degree of clean-up provided by many of these methods is usually limited because
extensive purification would invariably result in total loss of some residues. Other
groups have developed simple approaches such as simple ―dilute-and-shoot‖, ultra-
filtration or on-line column switching. Yamada et al. developed a screening method
capable of isolating 130 residues from bovine, porcine and chicken muscle [12].
Residues isolated included antibiotics, antibacterials, anthelmintics and hormonal
agents. Samples were dispersed on Na2SO4, extracted with ACN/MeOH and defatted
with hexane-saturated with ACN, prior to LC-MS/MS.
Stolker et al. isolated 101 veterinary drugs from milk prior to UPLC-ToF MS analysis
[13]. Milk samples were extracted with ACN and purified on Strata-X SPE cartridges
prior to analysis. Peters et al. adopted a similar approach to isolate 100 residues from
egg, fish and meat prior to UPLC-ToF MS analysis [421]. Ortelli et al. isolated 150
veterinary drugs from milk prior to UPLC-ToF MS detection [14]. Samples were
deproteinated with ACN, centrifuged and an aliquot of supernatant underwent ultra-
filtration. This group found that recovery exceeded acceptable values for several
residues, most noticeably MLs (≤10%), quinolones (98-807%), TCs (141-258%),
cefquinome (661%) and some benzimidazoles (>436%). The low recovery for MLs
was attributed to their larger molecular weight, while other poor recovery results were
attributed to ion enhancement/suppression effects.
Kaufmann et al. reported a method for isolating 100 residues from muscle, liver and
kidney prior to UPLC-ToF MS analysis [15]. Samples were extracted using the
bipolarity approach (see Fig. 6). Kaufmann identified difficulties in the isolation of
some polar residues, which adsorbed on precipitated proteins or glassware. This was
overcome by rinsing the sample and glassware with DMSO and complexing buffer.
A number of other multi-class methods have been developed by other groups but not
for such a wide range of analytes. Stubbings and Bigwood developed a QuEChERS
based method to isolate 41 residues from tissues prior to LC-MS/MS analyses [17].
Purification was carried out by dispersive-SPE on Bondesil NH2. An additional SCX-
SPE purification step was required to allow satisfactory detection of nitroimidazole
residues. Stubbings et al. also developed a method to isolate basic drugs, including
BZs, SAs, tranquilizers, quinolones, nitroimidazoles, levamisole, MG and LMG from
animal tissue [112]. Samples were extracted using a similar approach to their
QuEChERS assay but were purified on Bond Elut SCX SPE cartridges. MG and
LMG required an alternative extraction with citrate buffer/ACN and LLP with DCM
and NaCl prior to SCX SPE. Aguilera-Luiz et al. also developed a simple
QuEChERS based extraction procedure to isolate 18 drug residues from milk [72].
No further clean-up was performed.
Yang et al. developed a method for the analysis of 50 anabolic steroids in muscle,
liver and milk using UPLC-MS/MS [422]. Samples were hydrolysed and extracted
with MeOH prior SPE clean-up. HLB and C18 cartridges gave similarly high
recovery, but GCB-NH2 clean-up offered superior clean-up and lower matrix
suppression effects.
Chrusch et al. describe a multi-class, multi-residue method that is capable of
analysing 29 veterinary drugs, including NSAIDs, corticosteroids and anabolic
steroids, in bovine muscle and kidney [403]. After acid hydrolyis and protease
digestion, samples underwent LLE and purification by SPE. Yu et al. report a method
for the detection of 66 acidic and neutral drugs, including NSA IDs, corticosteroids
and anabolic steroids, in equine plasma by LC-MS/MS [404]. Plasma samples were
deproteinated, diluted with buffer and purified on Bond Elut Certify SPE cartridges
prior to analysis.
Several multi-class methods have been published for the analysis of antibiotics,
Chico et al. developed a simple method for isolating 39 antibiotics in tissue [423].
Samples were extracted with MeOH:H2O containing 0.1 M EDTA and diluted in H2O
prior to U PLC-MS/MS. Shao et al. developed a method to isolate 21 antibiotics (7
TCs, 14 quinolones) from porcine kidney, liver and muscle [424]. Samples were
extracted with EDTA-McIlvaine buffer and purified on Oasis HLB cartridges prior to
UPLC-MS/MS analysis. McDonald et al. developed a method for isolating 19
veterinary drugs (TCs, SAs, trimethoprim and dapsone) from muscle [425]. Residues
analysed include TCs, SAs, trimethoprim and dapsone. Samples were extracted with
0.1 M EDTA/ACN, concentrated and reconstituted in H2O prior to UPLC-MS/MS
analysis. Granelli and Branzell developed a screening method to isolate 19 antibiotics
from animal tissues [426]. Samples were simply extracted with 70% MeOH and
diluted with H2O prior to analysis by LC-MS/MS. Carretero et al. used automated
PLE to isolate 31 antibiotics from tissue [427].
Turnipseed et al. developed a rapid method for analysing 25 antibiotics, including
βLs, SAs, TCs, quinolones and macrolides, in milk [428]. Samples were extracted
with ACN and purified on Oasis HLB SPE cartridges. Additional purification was
performed by ultra-filtration prior to LC-MS/MS analysis. Li et al. developed a
screening method to isolate 18 drugs in shrimp [429]. Residues, including SAs,
quinolones, TPM dyes, OTC and toltrazuril sulphone, were extracted by LE and
purified on Oasis HLB cartridges.
6. Conclusions/future trends
In the area of banned substances there is a continued trend towards the development
of assays to detect ultratrace levels of residues of illegal substances. These methods
generally involve more intensive preparation of samples to allow detection of residues
to ng kg-1 levels. It is expected that the trend to develop more selective isolation
procedures using IAC and MIPs will continue but will be limited to illegal substances.
In contrast to licensed veterinary drugs, banned substances can not always be
combined in methods due to a number of specific sample preparation steps, such as
derivatisation (e.g. release of bound residues or deconjugation) and matrix type
(retina, thyroid, hair, etc.).
It can be seen from this paper that there is a growing trend to pack more and more
residues into methods particularly for veterinary drugs. Groups are now applying less
specific sample preparation approaches including ―dilute-and-shoot‖ or protein 
precipitation combined with ultra-filtration. In addition, more generic clean-up
procedures are being adopted that provide more basic clean-up such as QuEChERS or
the bipolar extraction approach for isolation and enrichment of polar and non-polar
residues. These new approaches coupled to modern mass spectrometry based
detection systems allow the analysis of >100 drug residues in food and provide
significant benefits. The authors of this review can testify to the benefits of multi-
class detection, where the implementation of an assay for anthelmintic drug residues
has resulted in fivefold reduction in solvent usage, through the redundancy of
traditional SPE and HPLC analysis. This has led to an increase in the output for these
substances in our laboratory from approximately 10,000 to 40,000 results per annum
for individual analytes. One can conclude that the scope of drug residue methods is
fast approaching that of pesticide residue methods.
A major problem with some of these multi-class methods is that there are often
compromises observed in LODs, chromatography and quantitation due to poor
linearity. As such many of these methods can be categorised as satisfactory for
screening purposes, particularly when analysis is carried out by Tof MS. Going
forward one can expect that future assays in this area may follow the route taken by
pesticide residue scientists, where assays might be divided into two groups for higher
polar and medium to non-polar compounds. In addition, a number of hurdles will
have to be overcome because the consolidation of methods will lead to increased
numbers of samples being passed through multi-class methods. This will initially
result in an increase in testing costs because residue analysis is traditionally a low
throughput technique. The current bottlenecks particularly in the area of sample
homogenisation of animal tissue will need to be addressed. Although, there are some
systems that can provide high throughput processing of tissue, these have not been
extensively evaluated in the field of residue analysis. Also the current 24 at a time
footprint adopted in traditional residue analysis purification is not ideally suited to
automated handling systems. The transfer of assays to 96-well format would be
advantageous to improve throughput of samples. Inevitably, this would require
adaptation in the areas of SPE, centrifugation, filtration and injection of samples.
There has been intense development in the area of sorbent technologies in recent years
leading to the development of generic polymeric HLB type sorbents, which appear to
offer the best all round generic SPE clean-up solution. Although the development of a
HILIC sorbent would be welcome for polar compounds.
If the above obstacles are overcome, one can expect that routine application of
screening assays for licensed veterinary drugs will be reduced. The analysis of
antibiotic residues using inhibitory assays will only have application in an industry
environment. Regulatory agencies will have to reconsider the approach to the design
of the national residue surveillance programs. The increase in the scope of residue
methods will invariably lead increased rates of non-compliant residue detection in
food similar to that in the field of pesticide residue analysis. As a result, decision
makers will have to consider the sampling numbers and cost benefit. It can be
concluded that developments in multi-class sample preparation procedures will
provide us with a clearer picture of the incidence of contaminant residues in food.
This may lead to a future cycle of development of targeted methods that will address
unique residue problems.
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Figure 1. Schematic showing matrix solid-phase dispersion (MSPD) procedure [81].
Reprinted from J. Chrom. A, 1069 (2005) 183, with permission from Elsevier.
Figure 2. Schematic of Dionex ASETM automated preesurised liquid extraction
(PLE) unit. Schematic is reproduced with permission from Dionex Corporation.
Figure 3. Diagram showing the formation of a molecularly imprinted polymer
(MIPs) [131]. Reprinted from J. Biochem. Biophys. Methods, 70 (2007) 133, with
permission from Elsevier.
Figure 4. Schematic showing the SymbiosisTM online automated SPE unit coupled to
a MS/MS system. The Sybiosis system consists of an autosampler with a sample
storage compartment, high pressure dispensing pumps and an automated cartridge
exchanger (ACE). Schematic is reproduced with permission from Spark Holland
B.V.
Figure 5. Schematic showing the operation of on-line turbulent flow chromatography
(TFC) [164]: (A) loading step—turbulent flow sweeps debris from sample matrix
through TFC extraction column while residues are retained. (B) Transfer step—
gradient mobile phase elutes analytes back out of TFC extraction column to analytical
column. (C) Eluting step—analytes are separated through eluting from analytical
column to detector. Reprinted from J. Chrom. B, 863 (2008) 64, with permission
from Elsevier.
Figure 6. Kaufmann et al. procedure for the isolation of 100 residues from muscle,
liver and kidney [15].
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Table 1
Table 1. Conventional sorbent phases used in solid phase extraction
Anion
Exchange
Cation
Exchange
Reversed Phase
Normal Phase
Mode
R=NH2
R=PSA1 (Primary/Secondary
Amine)
R=WAX (weak anion exchanger)
R=SAX (strong anion exchanger)
R=Diethylaminopropyl
R=PSA2 (Propylsulphonic Acid)
R=WCX (weak cationic
exchanger)
R=SCX (strong cationic
exchanger)
R=-(CH2)n-CH3 (n=1,3...17)
R= C6H11
R= C6H5
Al2O3
MgO3Si
R=OH
R=CN
R=Diol
Sorbent Type
Advantages:
Robust, stable
General clean-up
Broad application range
Suitable for polar extracts
Disadvantages:
Non-specific
Residual silanol group
effects
Not suitable for highly polar
analytes
Advantages:
Suitable for a range of
analytes
Generic clean-up
Suitable for polar analytes
Disadvantages:
Non-selective elution can
occur
Residual silanol group
effects
Limited operational pH
range
Advantages:
Greater specificity than
RP/NP SPE
Suitable for extraction of
acidic drugs
Disadvantages:
Slower kinetics than
reverse-phase or normal-
phase interactions
Advantages:
Greater specificity than
RP/NP SPE
Suitable for extraction of
basic drugs
Disadvantages:
Slower kinetics than
reverse-phase or normal-
phase interactions
Advantages/ Disadvantages
Corticosteroids
(ref. [108]– SiOH)
Macrocyclic
Lactones (ref. [109]
– alumina)
Pyrethroids
(ref. [110] –
MgO3Si)
Oxytetracycline,
sulfachloropyridazi
ne
(ref. [111] – Isolute
SAX)
Benzimidazoles
(ref. [106] – C18).
Β-agonists
(ref. [107] – C18)
17 basic drugs
(ref. [112] – Bond
Elut SCX)
Applications
Table 2
Table 2. Examples of selected polymeric sorbent phases used in solid phase extraction
Sorbent Type Advantages/Disadvantages 3Applications
Metharcylate-
Divinyl-
benzene
(Nexus)
Advantages:
No secondary silanol
effects
Higher surface area
than RP/NP bonded
phases, thus less
sorbent required
Large range of
compounds can be
Tetracyclines
(Ref. [113])
Styrene
Divinyl-
benzene
(SDVB)
extracted
Extraction may be
performed at
extremes of pH
No need for pre-
wetting
Hydrophobic
analytes
Pyrrolidone-
based
Copolymeric
Adsorbents
Oasis HLB: R= H
Oasis MCX: R=SO3 -
Oasis MAX: R= N+(CH3)2(C4H9)
Disadvantages:
R
Hydrophobicity of
most copolymers –
limits retention of
polar compounds
Irreversible
adsorption of highly
acidic/basic drugs on
mixed mode sorbents
Multi-class methods
(Ref. [15] – Oasis
HLB)
Aminoglycosides
(Ref. [114] – Oasis
HLB)
Closantel (Ref.
[115] – Oasis Max)
Table 3
Table 3. Examples of methods used for the analysis of stilbenes.
Number of
residues
Matrix Extraction
technique
Purification
technique
Additionalsample
preparation
Detection
system
Recovery
(%)
Sensitivity
(µg kg-1)
Ref
3 Tissues LSE (MTBE, acetate buffer+ β-
glucuronidase)
Automated SPE (Sep-Pak silica) - LC-MS/MS 59-108 0.03-0.3 [178]
3 Urine, plasma - IAC (sepharose gel, antibodies raised
against DES)
- GC-MS 28-96 0.04-0.45 [180]
3 (+ zeranol) Urine - IAC - GC-MS 63-109 0.15-0.84 [181]
3 Kidney, liver, milk,
urine
LE (MeOH/1% HAc, EtOAc) SLM (5% tri-n-octylphosphine oxide in n-
undecane/di-n-hexylether, 0.2 µm Teflon
filter)
- LC-MS 60-93 1.3-4.3 [182]
3 (+ 6 resorcyclic acid
lactones)
Urine LLE with diethylether, defatting with
hexane.
SPE (Oasis HLB + NH2) Enzymatichydrolysis
(helix promatia in
sodiumphosphate
buffer)
LC-MS/MS 95-108 <1 [183]
3 Urine, plasma IAC (sepharose 4B) Elution solvent:
Acetone:H2O (95:5, v/v)
- GC-MS 28-96 - [184]
Table 4
Table 4. Examples of methods used for the analysis of thyreostats.
Number of
residues
Matrix Extraction
technique
Purification
technique
Additional sample preparation Detection system Recovery
(%)
Sensitivity
(µg kg-1)
Ref
5 Tissue MSPD (silica gel) Wash solvent: chloroform Elution solvent:
(MeOH:chloroform)
GC-MS 47-97
72-97
10-50
2-10
[78]
[80]
5 Milk, urine MSPD (silica gel) Wash solvent:
MeOH:chloroform (5:95, v/v)
Elution solvent:
MeOH:chloroform (20:80, v/v)
GC-MS 50-103 1.6-4 [79]
6 Thyroid LSE (EtOAc) Automated GPC - UPLC-MS/MS 80-109
(except
tapezole-
20%)
50 [145]
7 Muscle,
liver,
thyroid,
urine, feed,
faeces,hair
Samples were diluted
with buffer, adjusted to
pH 2-3 (35 % HCl),
derivatised and extracted
with diethyl ether.
Tissue and feed required an initial
C18 SPE step
SPE (silica)
Solid samples were initially freeze-
dried and extracted with MeOH.
LC-MS/MS - 15 (muscle, liver,
thyroid) 5 (faeces)
50 (hair)
0.1-5.1 (urine)
[186]
6 Thyroid LSE (MeOH),
evaporated and
reconstituted in
DCM/cyclohexane
SPE (silica) - UPLC-MS/MS 40-79 25 [187]
5 Thyroid LSE (MeOH) SPE (silica) - LC-MS/MS - 0.9-1.9 [188]
6 Thyroid,
muscle
LSE (EtOAc), LLP
(hexane)
SPE (NH2) TAP + MBI required an additional
SPE (alumina) step
HPLC-UVor
LC-MS
- 5 [189]
Table 5
Table 5. Examples of methods used for the analysis of synthetic steroids and resorcyclic acid lactones.
Number of
residues
Matrix Extraction
technique
Purification
technique
Additional sample
preparation
Detection system Recovery
(%)
Sensitivity
(µg kg-1)
Ref
22 Urine Enzymatic hydrolysis (Helix
Promatia)
Automated SPE (C18 +
NH2)
- LC-MS/MS 74-114 ≤0.8 µg L-1 [147]
26 Muscle,
kidney fat
LSE (MeOH + NaOAc), SPE (silica + NH2) After LSE, defatting with
hexane, LLP (diethylether)
GC-MS/MS - ≤2.5 [192]
22 anabolic steroids Muscle LSE (MeOH) SPE (C18 + NH2)
Elution solvent:
ACN
Enzymatic hydrolysis
(subtilisine)
LC-MS/MS - <0.5 [193]
11 Kidney ,
muscle, liver,
milk
LLE (MeOH), defatting with hexane SPE (Oasis HLB, Silica,
NH2)
Enzymatic hydrolysis (Helix
Promatia)
LC-MS/MS 64-104 ≤0.12 [194]
22 Urine Dilution with H2O, adjustment to pH
7
SPE (C18)
Hydrolysis (abalone acetate
powder)
SPE (NH2)
- GC-MSn - 2.5
(10, α-
trenbolone)
[195]
7 Kidney fat PLE (containing alumina + anh.
Na2SO4)
50°C, 1 cycle, 5 min
SPE (C18) Pre-PLE: defatting with
hexane.
Elution with ACN
LC-MS/MS 17-58
(100-135% with
i.s.)
≤0.1 [198]
7 Tissues SFE (CO2) - - LC-MS/MS - 10 [199]
13 Muscle, skin,
fat
SFE (CO2) with in-line alumina
trapping
Alkaline hydrolysis, MTBE
extraction
- GC-MS - 2
(5, melengestrol)
[200]
E s t r a d i o l Serum LLE (acetate buffer) SPE (C18) - LC-MS/MS 86-93 ≤0.1 [201]
E s t r a d i o l Serum Enzymatic hydrolysis (β-
glucuronidase)
Acylation with 2,3,4,5,6-
pentafluorobenzoylchloride
LLP (ACN) Drying on Na2SO4 columns GC-MS/MS - ≤5 [202]
2 Serum LLE (1-chlorobutane) SPE (Bond-Elut silica) - GC-MS 80-120 <83 [203]
5 Serum LLE (acetate buffer) SPE (C18) - LC-MS/MS 90-97 100 [204]
8 progestogens Eggs MSPD (C18) Wash solvent:
MeOH:H2O (1 :9, v/v).
Elution solvent:
MeOH
SPE (GCB) LC-MS/MS 84-111 0.2-2 [205]
10 Muscle LSE (MeOH) Freezing-lipid filtration.
SPE (C8, silica, NH2)
- GC-MS 68-106 0.1-0.4 [206]
10 Tissues LSE (ACN), defatting with hexane SPE (C18) - GC-MS/MS 79-104 0.1-0.4 [207]
13 Muscle LLE (EtOAc:diethyl ether) SPE (Strata-X) Enzymatic hydrolysis (Helix
Promatia)
UPLC-MS/MS 98-102 ≤0.3 [208]
18 Urine Enzymatic hydrolysis (Helix
Promatia)
SPE (C18 + HLB) - GC-MS 60-122 <1 [209]
Table 6
Table 6. Examples of methods used for the analysis of β-agonists.
Number of
residues
Matrix Extraction
technique
Purification
technique
Additional sample preparation Detection system Recovery
(%)
Sensitivity
(jig kg-1)
Ref
9 Bovine liver, retina LSE (sodium citrate buffer) 96-well SPE (HCX mixed-
mode)
Enzymatic hydrolysis (Helix
Promatia)
LC-MS/MS 56-114 0.02-0.5 [32]
12 Bovine liver, retina Protease enzyme digestion
LLP (DCM :hexane)
SPE (Oasis HLB) LLE (MTBE + NaCl/EtOAc:IPA) LC-MS/MS 92-118 0.5-5 [33]
4 β-agonists Urine IAC (Fractoprep, Merck) Elution solvent:
EtOH :0.03M acetate buffer,
pH 4 (8:2, v/v)
- HPLC-EC 65-75 - [58]
8 β-agonists Bovine urine LLE (0.05M acetate buffer,
pH5.2)
SPE (C18) Elution solvent:
MeOH + 1% TEA
LC-MSn 71-82 - [107]
Clenbuterol Feed, liver, urine, milk MIPs (clenbuterol template) Elution solvent:
MeOH:TFA (99:1, v/v)
- H PLC-PDA 91-93 5 (20 for liver) [127]
10 Urine Urine was mixed with
polyclonal antibodies raised
against salbutamol
Ultra-filtration - ELISA - 0.14 [141]
7 Liver, urine LE (acetate buffer)
NaOH hydrolysis
SPE (C18)
LLE (MTBE)
Hexane wash in SPE step. LC-MSn - 0.05-0.2 [213]
22 Bovine and porcine urine,
feed, hair
LE (NaOAc buffer) SPE (Bond Elut mixed-mode) Enzymatic hydrolyis (urine), acid
hydrolysis (feed), NaOH
digestion (hair)
LC-MS/MS
UPLC-MS/MS
85-111
(urine)
≤10 [214]
10 Bovine muscle Enzymatic digestion.
LLE (EtOAc)
MIPs Defatting with heptane LC-MSn 84-134 0.13-1 [215]
8 β-agonists Bovine urine Dilution with H2O
Enzymatic hydrolysis
MIPs
Elution solvent:
MeOH:HAc (9:1, v/v)
Enzymatic hydrolysis LC-MS/MS 32-66 0.01-1.9 [216]
Ractopamine Porcine LE (ACN + 4M potassium
carbonate)
MIPs (ractopamine template) Defatting with hexane
MIPs coulple on-line to HPLC
HPLC-FL 56-67 4.6 [217]
15 β-agonists Urine MIPs (MIP4SPE ,MIP
Technologies, Lund, Sweden)
Elution solvent:
MeOH:HAc (9:1, v/v)
- LC-MS/MS 72-111 <3 [222]
6 β-agonists Bovine urine, hair LE (PBS) SPE (Extrelut 5) Elution solvent:
hexane:DCM (8:2, v/v)
GC-MS 65-85 0.5-2.5 [223]
5 β-agonists Bovine urine IAC (sepharose) Elution solvent:
2% HAc
Coupled on-line via HPLC (C18) LC-MS/MS 94-108 - [224]
Table 7
Table 7. Examples of methods used for the analysis of amphenicols.
Number
of
residues
Matrix Extraction
technique
Purification
technique
Additional sample
preparation
Detection system Recovery
(%)
Sensitivity
(rig kg-1)
Ref
CAP Honey QuEChERS (ACN) DSPE (PSA) - LC-MS/MS 83-89 0.2 [67]
CAP Milk MIPs Elution solvent:
H2O:MeOH (1:9, v/v) + 1% HAc
- LC-MS/MS 96-102 0.06 [130]
FF + FFA Fish, shrimp, porcine muscle LSE(fish+ shrimp;ACN:EtOAc,
porcine; EtOAc:NaOH)
SPE (Oasis MCX) Defatting with hexane GC-ECD 72-110 0.5-1 [225]
4 Chicken muscle LSE (EtOAc) SPE (Oasis MCX) Defatting with hexane LC-MS/MS 95-107 0.1-1 [226]
4 Poultry, porcine muscle, liver LSE (EtOAc + 2% NH4OH) SPE (Oasis HLB) Defatting with hexane GC-MS 79-105 0.1-0.5 [227]
4 Aquatic species LSE (acetone) LLP (DCM) Defatted with hexane LC-MS 71-107 0.1-1 [228]
CAP Shrimp LSE (EtOAc:NH4OH + ACN) LLP (hexane + EtOAc) - Microbial assay 96 1 [230]
FF + FFA Fish feed LSE (EtOAc) LLP (hexane + PBS buffer) Dilution with buffer ELISA 98-121 2000 [231]
FF + FFA Porcine muscle LSE (PBS buffer) - Dilution with buffer ELISA 5 8-97 4 [232]
CAP Muscle MSPD (C18) Wash solvent:
hexane+ACN:H2O(5:95,v/v).
Elution solvent:
ACN:H2O (1:1, v/v)
LLP (EtOAc) GC-ECD + GC-MS 93-98 1.6 [234]
CAP Honey, urine, milk, plasma MIPs (chloramphenicol template) Elution solvent:
Honey:MeOH:DCM(1:9,v/v).
Urine: MeOH.
Milk + plasma:
MeOH:HAc:H2O (89:1:10, v/v/v)
- LC-MS/MS 57-120 0.02-0.03 [235]
CAP Porcine muscle IAC (sepharose 4B) Elutionsolvent:
MeOH
- HPLC-UV 66-75 - [236]
CAP Milk, egg IAC (silica) Elution solvent:
Glycine 0.2M:NaCl 0.5M (pH 2.8)
- HPLC-UV 80-100 - [237]
CAP Porcine liver, kidney, muscle,
urine
IAC (agarose) Elution solvent:
EtOH: H2O (7:3, v/v)
- GC-ECD 54-96 - [238]
CAP Chicken liver, muscle IAC (sepharose 4B) Elutionsolvent:
MeOH
- GC-EC 74-97 - [239]
CAP Shrimp IAC (silica [sol-gel]) Elution solvent:
ACN: H2O (4:6, v/v)
- HPLC-UV 68 - [240]
FF Swine feed LSE (ACN:H2O) SPE (Envi-Carb; GCB) - HPLC-UV 99-101 - [241]
Table 8
Table 8. Examples of methods used for the analysis of nitrofurans.
Number of
residues
Matrix Extraction
technique
Purification
technique
Additional sample preparation Detection system Recovery
(%)
Sensitivity
(µg kg-1)
Ref
4 Porcine retina LLE (EtOAc) - Overnight hydrolysis + derivatisation LC-MS/MS - - [36]
AOZ Porcine liver LLE (EtOAc) SPE (MAX + HLB) Samples were pre-washed and derivatised
(HCl) overnight
HPLC-UV + LC-
MS/MS
84-90 1 [50]
5 Poultry muscle LLE (EtOAc) Ultra-centrifugation Samples were derivatised (HCl) overnight
prior to LLE
Samples were pre-washed (protein-bound
residues only)
LC-MS/MS - 0.5 [247]
4 Honey Dissolve samples in 0.12M
HCl
SPE (Oasis HLB) - LC-MS/MS - 0.2-0.3 [251]
4 Honey Dissolve samples in 10%
NaCl
SPE (Oasis HLB) Hydrolysis, derivatisation, LLP (EtOAc +
hexane)
LC-MS/MS 92-103 0.25 [252]
4 Milk LLP (hexane) SPE (Oasis HLB) Overnight hydrolysis + derivatisation LC-MS/MS 83-104 ≤0.2 [253]
4 Milk LLE (EtOAc) - Overnight hydrolysis + derivatisation LC-MS/MS 91-107 0.12-0.29 [254]
4 Chicken tissues,
eyes
LLE (EtOAc) - Samples were derivatised (HCl) overnight
prior to LLE
Samples were pre-washed (protein-bound
residues only)
LC-MS/MS - - [255]
Table 9
Table 9. Examples of methods used for the analysis of nitroimidazoles.
Number of
residues
Matrix Extraction
technique
Purification
technique
Additional sample preparation Detection system Recovery
(%)
Sensitivity
(µg kg-1)
Ref
7 Poultry muscle, egg LSE (potassium phosphate buffer
+ EtOAc)
Defatting with hexane - LC-MS/MS 88-111 0.07-0.36 [256]
7 Poultry, porcine
muscle
Protease digestion
LLE (NaCl:KH2PO4 buffer)
SPE (EXtrelut NT20) Defatting with hexane GC-MS 94-118 0.65-2.8 [261]
4 Porcine liver LSE (EtOAc) SPE (Oasis MCX) Defatting with hexane LC-MS/MS 83-98 0.1-0.5 [266]
2 Poultry, porcine
tissues
LSE (Na2SO4 + toluene) SPE (NH2) - GC-MS 72-106 0.1-1.5 [267]
6 + 4 NFs Porcine muscle Acid hydrolysis (0.2M HCl) SPE (Oasis HLB) - LC-MS/MS 93-106 0.01-0.2 [269]
5 Poultry muscle LSE (EtOAc) - - SPR - 2 [270]
7 Porcine plasma Protease digestion
LLE (NaCl: KH2PO4 buffer)
SPE(Chromabond
XTR)
Defatting with hexane LC-MS/MS 93-123 0.25-1 [271]
10 Bovine, porcine,
ovine, avian, equine
plasma
LLE (ACN + NaCl) LLP (hexane) - LC-MS/MS 101-108 0.52-1.52 [272]
7 Muscle LSE (EtOAc) SPE (SCX) Elution solvent:
28% NH3OH:ACN (5:95, v/v)
HPLC-UV 71-100 0.2 [273]
4 Egg, plasma, faeces LE (aqueous buffer) SPE (EXtrelut) LLP (isooctane) HPLC-UV - 10 [274]
7 Kidney, liver, serum,
milk, egg
LE (ACN) Ultra-centrifugation - SPR - 1-3 [275]
Table 10
Table 10. Examples of methods used for the analysis of aminoglycosides.
Number of
residues
Matrix Extraction
technique
Purification
technique
Additional sample preparation Detection system Recovery
(%)
Sensitivity
(µg kg-1)
Ref
9 Milk MSPD (sand) PLE (H2O)
70°C, dynamic mode (1 mL min-1), 4
min
- LC-MS/MS 70-92 2-13 [83]
13 Various LSE (5% TFA) Ion-pair SPE (Oasis HLB) Elution solvent:
ACN:0.2M HFBA (8:2, v/v)
LC-MS/MS 61-116 2-25 [114]
11 Muscle,
liver
LSE (5 % trichloroacetic acid) SPE (WCX) - LC-MS/MS 40-80 15-40 [276]
Table 11
Table 11. Examples of methods used for the analysis of β-lactams.
Number of
residues
Matrix Extraction
technique
Purification
technique
Additional
sample
preparation
Detection system Recovery
(%)
Sensitivity
(rig kg-1)
Ref
10 β-lactams Bovine Kidney LSE (ACN:H2O, 8:2, v/v) DSPE (C18) - LC-MS/MS 58-75 <MRL [64]
10 Milk Centrifugation On-line SPE (C18) - LC-MS/MS 83-139 0.0144-0.5115 [160]
3 penicillins Milk LLE (ACN) LLP (phosphate buffer, DCM,
petroleum ether)
- HPLC-UV 94-103 10 [278]
11 Bovine kidney LSE (ACN:H2O, 4:1 v/v) DSPE (C18) - LC-MS/MS 87-103 - [279]
6 penicillins Bovine liver, kidney,
muscle
Muscle – LSE (2% NaCl)
Liver,kidney – LSE (5% sodium
tungstate, 0.17 M sulfuric acid,
2% NaCl)
Ion-exchange SPE (Bond Elut
C18 + Sep-Pak Accell Plus
QMA)
- LC-MS/MS 77-101 2-10 [281]
5 Milk - RAM (C8, C18, phenyl, cyano) - HPLC-UV 91-94 50-100 [282]
15 Bovine muscle, kidney,
milk
LE (ACN:H2O) SPE (Oasis HLB) - LC-MS/MS 71-116 4.6-359 [283]
11 Milk LLE (ACN) - - LC-MS/MS 57-88 1-25 [284]
5 penicillins Porcine muscle MSPD (C18) Wash solvent: hexane.
Elution solvent: MeOH (4°C)
SPE (C18) cleanup HPLC-UV 45-130 20 [286]
8 penicillins Milk, porcine liver, kidney Milk - LLE (phosphate buffer,
pH8 + hexane)
Tissue – LSE (MeOH)
Milk – SPE (C18) - HPLC-UV + LC-MS 90-111 (UV)
83-95 (MS)
2.27-4.06 (UV)
0..01-0.51 (MS)
[287]
4 cephalasporins Milk LLE (ACN) SPE (C18) - HPLC-UV 69-93 7-11 [288]
Table 12
Table 12. Examples of methods used for the analysis of macrolides and lincosamides.
Number of
residues
Matrix Extraction
technique
Purification
technique
Additional sample preparation Detection system Recovery
(%)
Sensitivity
(µg kg-1)
Ref
5 Milk, yoghurt MSPD (sand) Elution solvent:
H2O (70°C, 30mM formic acid)
- LC-MS/MS 86-117 0.2-7 [85]
5 Honey LLE (trisbuffer, pH
10.5)
SPE (Oasis HLB) - LC-MS/MS 77-103 <0.25 [293]
6 macrolides Eggs, honey, milk LLE (ACN or 0.1 M
phosphate buffer, pH 8)
SPE (Oasis HLB) - UPLC-QToF MS or
LC-MS/MS
88-115 0.01-0.5 [295]
7 macrolides Liver, kidney LSE (EDTA:McIlvaine’s
buffer)
SPE (Oasis HLB) Elutionsolvent:
MeOH
HPLC-PDA 40-93 15-50 [296]
9 macrolides Meat, fish LSE (0.2 %
metaphosphoric
acid:MeOH,6:4)
SPE (Oasis HLB) - LC-MS 70-93 10 [298]
9 Bovine,porcine,
poultry muscle
LSE (ACN) Dilution (H2O) + defatting with hexane - LC-MS/MS 62-117 0.36-0.7 [299]
5 Feed PLE (Acetone:H2O
(65 :35, v/v) pH 2.0)
80°C, 2 cycles, 5 min Mixsample+sand
SPE (HIILIC)
IST
(screening test)
57-96 5400-10000 [300]
Table 13
Table 13. Examples of methods used for the analysis of quinolones.
Number of
residues
Matrix Extraction
technique
Purification
technique
Additional sample
preparation
Detection system Recovery
(%)
Sensitivity
(µg kg-1)
Ref
7 Bovine tissues MSPD (sand) Elutionsolvent:
H2O (100°C)
- LC-MS/MS 87-109 2-9 [86]
8 Milk MSPD (sand) Elutionsolvent:
H2O (90°C)
- LC-MS/MS 93-110 0.3-1.5 [87]
7 Eggs MSPD (sand) Elution solvent:
H2O+ 50 mMformic
acid (1 00°C)
- LC-MS/MS 89-103 0.2-0.6 [88]
13 quinolones +
6 sulphonamides
Muscle LSE (MeOH:H2O, 8:2) IAC (sepharose 4B) Elution solvent:
MeOH:H2O:NH3
(90:9.8:0.2, v/v/v)
LC-MS/MS 75-104 0.5-3 [122]
10 Chicken muscle LSE (0.1M PBS, pH 7) IAC (sepharose 4B) Elution solvent:
70%MeOHinPBS
HPLC-FL 82-101 0.1-0.15 [123]
13 Feed PLE(0.2%MPAH2O:ACN
(70:30, v/v) pH 2.6)
- AutomatedSPE(Oasis
HLB)
LC-PDA; LC-FI 31-103 400-1500 [149]
10 Bovine,porcine,ovine
muscle
LSE (0.1 % TFA in MeOH) SPE (LiChroLut RP-18) - HPLC-UV 92-107 10-18 [304]
22 Milk LLE (EDTA-McIlvaine buffer) SPE (Bond Elut Plexa) - UPLC-MS/MS 41-95 0.01-0.34 [305]
11 Pig kidney LSE (ACN) SPE (SDB-RPS) - LC-MS/MS 99-104 0.3-1.5 [307]
4 Eggs SFE (CO2 + 20% MeOH) 300 bar, 60°C - HPLC-FL 83-96 10 [308]
8 Avian muscle PLE (DCM)
In-line SPE (Oasis MCX)
50°C, 1 cycle, 0 min Mix sample +
diatomaceousearth.
SPE (Oasis HLB)
CE-MS/MS 63-112 0.040-0.140 [309]
4 Urine, tissue MIPs (enrofloxacin template) Elution solvent:
ACN + 4% formic acid
SPE (Oasis HLB) HPLC-UV 70-96 30 [310]
5 Eggs and tissue MIPs (ofloxacin template) Elution solvent:
ACN:TFA (99:1, v/v)
M I-MSPD HPLC-FL 86-105 0.05-0.09 [311]
7 Muscle LSE (PBS) SPE (Oasis HLB) Elutionsolvent:
MeOH
HPLC-FL 70-106 0.1-0.3 [312]
5 Milk LLE (ACN) SPE (Strata X) Elution solvent:
ACN:1%TFA(75:25,
v/v)
LC-UV,LC-FL,LC-MS,
LC-MS/MS
80-100 9-13,3-8,1-5,
0.5-1
[313]
7 Gilthead seabream LSE (0.1M NaOH) SPE (Oasis HLB) Elution solvent:
0.1%TFAin ACN+
ACN
LC-MS/MS 90-132 2-2.7 [314]
9 Pig kidney LSE(0.35% m-phosphoric
acid:ACN, 73:27)
SPE (ENV+ Isolute) - LC-ToF MS ≥63 0.1-2 [315]
Table 14
Table 14. Examples of methods used for the analysis of sulphonamides.
Number of
residues
Matrix Extraction
technique
Purification
technique
Additional sample preparation Detection system Recovery
(%)
Sensitivity
(µg kg-1)
Ref
6 Milk LLE (ACN) Ultra-filtration - LC-MS/MS 90-125 5-10 [19]
6 Chicken
muscle
LSE (ACN) DSPE (C18) - HPLC-FL 90-95 1-5 [62]
12 Milk, eggs MSPD (sand) Elution solvent:
H2O (milk 75°C, egg 100°C)
- LC-MS 77-92 1-3 [82]
24 Muscle LLE (ACN) LLP (H2O: EtOAc) Defatting with hexane UPLC-MS/MS 68-114 0.04-0.37 [319]
10 Tissues LLE (acetone:
chloroform)
SPE (cation-exchange) - HPLC-UV 63-77 3-14 [320]
7 Milk LLE (acetone:
chloroform)
SPE (cation-exchange) - HPLC-PDA 56-8 1 20 [321]
10 Egg LLE(DCM:acetone
+ HAc)
SPE (cation-exchange) - LC-MS/MS 100 15 [322]
4 Muscle, liver LSE(ACN:1-
propanol)
SPE (Cleanert-PEP) - CZE 83-95 4-6 [323]
12 Tissues LSE (ACN) SPE (C18) Derivatisation + SPE (silica) HPLC-UV 65-103 3-5 [324]
8 Honey MSPD (C18) Wash solvent: hexane
Elution solvent: EtOAc
Derivatisation + SPE (silica) HPLC-UV 63-96 4 [325]
13 Bovine
muscle, baby
food
MSPD (C18) Elution solvent: MeOH - LC-MS/MS 87-101 0.06-0.35 [326]
9 Chicken
muscle, liver
LSE (MeOH:H2O) IAC (sepharose 4B) - HPLC-UV 74-109 2 [327]
6 SAs + 3 TCs +
pyrimethanime
Mild LLE (20% TCA +
McIlvaine buffer)
SPE (Oasis HLB) - LC-MS/MS 72-79 0.48-2.64 [328]
12 Cattle, fish
muscle
MSPD (sand) Elutionsolvent:
H2O (80°C)
- LC-MS/MS 73-104 3-15 [329]
6 Muscle MSPD (alumina) Elution solvent:
H2O:EtOH (7:3, v/v)
- HPLC-PDA 85-101 6-40 [330]
10 Porcine
Kidney
SFE (CO2 + MeOH) 361 bar, 90 °C - SFC-MS - - [331]
13 Meat and
infant food
PLE (H2O) 160°C, 1 cycle, 15 min MSPD LC-MS/MS 70-101 0.4-2.6 [332]
12 Pork muscle PLE (H2O) 160°C, 1 cycle, 5 min Mix sample + diatomaceous earth.
SPE (Oasis HLB)
CE-MSn 76-98 1.56-12.5 [333]
Table 15
Table 15. Examples of methods used for the analysis of tetracyclines.
Number of
residues
Matrix Extraction
technique
Purification
technique
Additional sample
preparation
Detection system Recovery
(%)
Sensitivity
(µg kg-1)
Ref
7 Muscle MSPD (sand) Elutionsolvent:
H2O (70°C)
- LC-MS/MS 88-109 1-9 [84]
5 Bovine Muscle LSE (0.3M citrate buffer, pH 4) SPE (Abselut Nexus) Elution solvent:
MeOH:ACN:0.05Moxalic
acid (3:3:4, v/v/v)
HPLC-PDA 99-103 25-40 [113]
7 Bovine liver, kidney LSE(15% TFA+ 0.4Moxalate
buffer, pH 4)
SPE (Discovery [liver], Lichrolut
[kidney])
Elution solvent:
MeOH:ACN:oxalic acid
(30:30:40, v/v/v)
HPLC-PDA 92-125 10-54 [334]
3 Porcinemuscle,
liver
LSE (EDTA-McIlvaine buffer,
pH 4)
SPE (Oasis HLB) - LC-MS/MS+HPLC-
FL
65-90 50(muscle)
100 (liver)
[336]
10 Milk LLE(0.1MEDTA-McIlvaine
buffer)
SPE (Oasis HLB) - LC-MS/MS 74-101 0.5-10 [337]
7 Milk LLE (20% TCA) SPE (Oasis HLB) - LC-MS/MS 90-101 5-25 [338]
7 Bovine,porcine
muscle
LSE (0.4 M oxalate buffer, pH
4)
SPE (Nexus) - HPLC-PDA 89-114 3-14 [339]
5 Honey LLE (0.1 M Na2EDTA-
McIlvaine buffer, pH 4)
Automated SPE (C18) - HPLC-UV 84-1 21 5-12 [340]
4 Porcine Kidney MIPs (TC + OTC template) Elution solvent:
MeOH:1M KOH (9:1, v/v)
- HPLC-UV - - [341]
4 Lobster,duck,
honey, egg
Lobster– LSE(McIlvaine
buffer)
Duck,Honey– LE(5%HCl+
HAc:MeOH)
Egg - MSPD (silica)
MIPs (TCtemplate)– lobster, duck,
honey
Elution solvent:
MeOH:0.1M KOH)
- LC-MS/MS 95-103 0.1-0.3 [342]
4 Bovine,porcine,
poultry, lamb
muscle
Dionex ASE 200® PLE (H2O) 70°C, 1 cycle, 10 min Samples were pre-mixed
with sand
SPE (Oasis HLB)
LC-MS/MS >89 0.5-1 [343]
7 Cheese MSPD (sand) Elutionsolvent:
H2O (70°C)
- LC-MS/MS 96-117 1-2 [346]
10 Milk LLE (0.1M EDTA:McIlvaine’s
buffer)
SPE (Oasis HLB) Elution solvent:
MeON:EtOAc (9:1, v/v)
LC-MS/MS 74-101 0.5-10 [347]
Table 16
Table 16. Examples of methods used for the analysis of anthelmintics.
Number of
residues
Matrix Extraction
technique
Purification
technique
Additional sample
preparation
Detection system Recovery
(%)
Sensitivity
(µg kg-1)
Ref
38 Bovine liver, milk QuEChERS (ACN + MgSO4) DSPE (C18) - LC-MS/MS 61-115 5 [16]
12 BZs Bovine liver LSE (EtOAc) SPE (C18) Elutionsolvent:
EtOAc
HPLC-UV 25-100 - [106]
5 MLs Liver LSE (isooctane) SPE (alumina) Elution solvent:
MeOH:EtOAc (7:3, v/v)
HPLC-FL 80-9 2 [109]
5 MLs Bovine liver LSE (ACN) SPE (alumina + C18 ) Elutionsolvent:
ACN
HPLC-FL 73-97 2 [348]
3 MLs Milk LLE (ACN) SPE (alumina) - HPLC-FL 72-8 1 1 [349]
5 MLs Milk LLE (ACN) SPE (C8) - HPLC-FL - 0.1 [350]
6 MLs Milk LLE (ACN) SPE (C18) - LC-MS/MS >95 0.14-0.25 [351]
22 BZs Muscle LSE (ACN + 0.1% formic
acid)
Centrifugation - LC-MS/MS - 5-10 [352]
23 Milk LLE (ACN) Defatting with hexane Acid hydrolysis LC-MS/MS - 1-5 [353]
17 BZs Milk LLE (ACN) On-line SPE (Oasis
MAX)
- LC-MS/MS 68-107 2 [354]
8 Bovine kidney LSE (ACN + 1% HAc) SPE (Oasis MAX) - LC-MS/MS 77-8 1 - [355]
4 MLs Bovine liver, muscle LSE (ACN) SPE (C18) Elutionsolvent:
ACN
HPLC-FL 70-94 0.5-1 [356]
4 MLs Bovine liver IAC (sepharose 4B) Elution solvent:
MeOH
- HPLC-FL 79-116 - [357]
4 MLs Bovine liver, muscle IAC (sepharose 4B) Elution solvent:
MeOH
- LC-MS/MS 63-84 - [358]
5 MLs Liver SFE (CO2) 300 bar, 100°C SPE (alumina) HPLC-FL 76-97 2 [359]
10 BZs Liver SFE (CO2) 690 bar, 80°C SPE (SCX) HPLC-UV 51-115 50 [360]
5 MLs Bovine liver LSE (ACN) SPE (alumina (NP),
C18(RP))
Elutionsolvent:
ACN
HPLC-FL 72-86 - [361]
Table 17
Table 17. Examples of methods used for the analysis of anticoccidials.
Number of
residues
Matrix Extraction
technique
Purification
technique
Additionalsample
preparation
Detection system Recovery
(%)
Sensitivity
(µg kg-1)
Ref
6 Chicken egg, fat, liver,
muscle, plasma
LLE (acetone:THF, 6:4) LLP SPE (silica) LC-MS 61-114 1-7
(4-10, plasma)
[7]
14 Chicken muscle, egg LLE (ACN) - Sampleswerepre-mixedwith
Na2SO4
LC-MS/MS 78-125 0.1-0.2 [363]
5 Egg LLE (ACN) - - LC-MS/MS 42-1 13 0.75-6 [364]
3 Tissue, egg LE (H2O + MeOH) LLP (hexane:toluene) - LC-MS/MS 73-117 1 [365]
4 Liver, eggs LLE (ACN) SPE (silica) Samplesweredispersedon
Na2SO4
LC-MS/MS 93-106 2.5-50 [366]
5 Liver, eggs LLE (ACN) SPE (silica) Samplesweredispersedon
Na2SO4
LC-MS/MS 86-118 2.5 [367]
9 Muscle, egg LLE (ACN) SPE (silica) Samplesweredispersedon
Na2SO4
LC-MS/MS 40-60 0.07-0.6 [368]
4 ionophores Egg LLE (ACN) - - LC-MS/MS 85-120 1 [369]
Toltrazuril +
halofuginone
Egg LLE (EtOAc) SPE (Oasis HLB) LLP(hexane:trisodium
phosphate buffer)
HPLC-UV or LC-MS/MS - 10-30 (UV)
1 (MS)
[370]
Toltrazuril +
toltrazuril sulphone
Muscle, egg LLE (acetone:THF, 6:4) LLP (DCM) Defatting with hexane LC-MS 91-98 <2.5 [371]
12 Poultry liver LLE (ACN) SPE (Oasis HLB) DefattingonaluminaSPE
columns
LC-MS/MS 81-129 0.04-10.9 [372]
Table 18
Table 18. Examples of methods used for the analysis of carbamates.
Number of
residues
Matrix Extraction
technique
Purification
technique
Additional sample
preparation
Detection
system
Recovery
(%)
Sensitivity
(µg kg-1)
Ref
10 Liver LSE (DCM) GPC (SX-3 resin, 200-400 mesh)
SPE (NH2)
Samples were pre-
mixed with Na2SO4
HPLC-FL >80 - [374]
3 Chicken, beef
muscle
Online-SFE (CO2)
(219 atm, 90°C)
- - SFC-MS 53 175-200 [375]
6 Muscle LLE (ACN)
LLP (hexane)
SFE (CO2)
(329 bar, 60°C)
- HPLC-FL or
GC-MS
>80 1 [376]
5 Honey Dissolved in H2O SPE (C18) - LC-MS >75 <20 [377]
7 Honey LLE (MeOH:EtOAc) SPE (Florisil® + Na2SO4) - GC-MS >75 ≤8.7 [378]
Table 19
Table 19. Examples of methods used for the analysis of pyrethroids.
Number of
residues
Matrix Extraction
technique
Purification
technique
Additional sample
preparation
Detection system Recovery
(%)
Sensitivity
(µg kg-1)
Ref
32 pesticides Milk, egg QuEChERS(ACN+ 1%HAc,MgSO4,
NaOAc)
DSPE (PSA, C18, MgSO4) - GC-MS + LC-MS/MS 70-120 <10 [63]
4 Honey LLE (H2O:acetone, 1:1) SPE (C18, Florisil®) Elution solvent:
MeOH, ACN
HPLC-UV 96-99 0.2-1.6 [110]
18 pesticides Beef fat Melted fat was mixed with Florisil® SPE (Florisil® + C18) - GC-ECD 88-137 3-118 [381]
3 Honey LLE (hexane:acetone,6:4) or
SFE (CO2 + 10% ACN)
(400 bar, 90°C)
SPE (Florisil®) - GC-ECD + GC-MS 75-94 <10 [383]
12 Milk SPME (100°C) (polydimethylsiloxane
(PDMS)/divinylbenzene
(DVB) coating)
Sample was diluted
with H2O
GC-µECD 69-120 - [384]
26 pesticides Muscle PLE (light petroleum)
(70°C, 1 cycle, 10 min)
SPE(ExtrelutNT3+ C18)+
Florisil® mini-cartridge
Samples were pre-
mixed with Na2SO4 +
sand
GC-MS/MS 84-99
(pyrethroids)
1-8 [385]
32 pesticides Cattle feed MSPD (alumina + Na2SO4) Elution solvent:
EtOAc
Florisil® was added as a
co-column
GC-ECD >75 0.03-1.5 [386]
Table 20
Table 20. Examples of methods used for the analysis of sedatives.
Numberof
residues
Matrix Extraction technique Purification
technique
Additional sample
preparation
Detection system Recovery
(%)
Sensitivity
(µg kg-1)
Ref
6 Porcine muscle LSE (ACN) SPE (C18) - LC-MS/MS - 5 [387]
7 Urine Dilution with TEA carbonate-bicarbonate
buffer
SPE (C18) LLP (MTBE) GC-MS >70 5-50 [388]
11 + 19 β-blockers porcine kidney,
liver, muscle;
bovine muscle
LSE (ACN) SPE (NH2) Samples were pre-mixed with
Na2SO4
LC-MS/MS 84-113 ≤0.6 [389]
7 Bovine + porcine
kidney
LSE (ACN) SPE (Oasis HLB) - LC-MS/MS >75 <1 [390]
7 Porcine kidney +
muscle
LSE (ACN) SPE (Oasis HLB) - LC-MS/MS 83-109 1-10 [392]
2 Kidney LSE (ACN) SPE (Oasis MCX) - HPLC-FL 86-94 3-10 [393]
6 Porcine kidney LSE (ACN:HCl, 75:25) LLP (NaOH + DCM) - ELISA - 5-20 [394]
Table 21
Table 21. Examples of methods used for the analysis of non-steroidal anti-inflammatory drugs.
Number of
residues
Matrix Extraction
technique
Purification
technique
Additional sample preparation Detection
system
Recovery
(%)
Sensitivity
(µg kg-1)
Ref
12 Corticosteroids Bovine hair, urine,
muscle
LE SPE (C18 (RP), SiOH (NP)) Elution solvent:
Diethylether (RP),
EtOAc:cyclohexane:HAc (90:5:5, v/v/v)
LC-MS/MS 37.7-
66.6%
0.04-0.07
(muscle, urine)
2.9-9.3 (hair)
[108]
3 Milk LLE (ACN) Centrifugation - LC-MS/MS 92-98 0.5-1 [395]
6 Bovine muscle LLE (ACN) SPE (Oasis HLB) - LC-MSn - 21-59 [396]
4 Milk, bovine,
porcine muscle
LLE (MeOH) LLP (hexane) - LC-MS/MS 82-128 20-130 [397]
7 Milk LLE ( ACN + NaCl) LLP (hexane) - LC-MS/MS 96-102 0.34-61 [398]
14 Plasma, serum Hydrolyis + protein
denaturisation (HCl)
SPE (C18) - LC-MSn 72-101 <25 [399]
4 Milk LLE (ACN) SPE (C18) - GC-MS/MS 104-112 0.59-2.69 [400]
16 Bovine, buffalo
milk
LLE (ACN:MeOH, 9:1) SPE (C18) - HPLC-PDA
(screen)
LC-MSn
(confirm)
69-97 2-15 [401]
17 Equine plasma,
urine
Acidification (pH 2-3)+
LLE (diethyl ether)
LLP
(plasma – sodium hydrogencarbonate buffer)
(urine – sodium carbonate:sodium
hydrogencarbonate buffer, 2 :1)
- GC-MS 23-100 5-25 [402]
13 Plasma, serum Hydrolyis + protein
denaturisation (HCl)
SPE (C18) - HPLC-PDA 73-104 <25 [406]
5 Corticosteroids Milk LLE (20% TFA) SPE (Oasis HLB) Elution solvent:
MeOH
LC-MS/MS 97-111% ≤0.4 [407]
5 Corticosteroids Bovine liver, milk,
urine, faeces
IAC (Tesyl gel) Elution solvent:
MeOH:H2O (8:2,v/v)
- GC-MS 50-80% - [408]
Table 22
Table 22. Examples of methods used for the analysis of triphenylmethane dyes.
Number of
residues
Matrix Extraction
technique
Purification
technique
Additional sample preparation Detection system Recovery
(%)
Sensitivity
(jig kg-1)
Ref
MG + LMG Fish LSE (ACN, ammonium acetate buffer, hydroxylamine HCl,
p-toluene sulphonic acid)
LLP (DCM) Automated SPE (alumina +
propylsulfonic acid)
LC-MS/MS 5 8-68 0.24 [409]
13 Fish LSE (ACN + 0.1M ammonium acetate buffer) LLP (DCM) SPE (Isolute SCX-2) LC-MS/MS - 1.1-14 [410]
4 Aquatic products LSE (ACN, McIlvaine buffer, p-toluene sulphonic acid,
N,N,N’,N’-tetramethyl-1,4-phenylenediamine
dihydrochloride)
LLP (DCM) SPE (alumina + Oasis MCX) LC-MSn 81-116 0.5 [415]
4 Fish LSE (ACN, ammonium acetate buffer, hydroxylamine HCl,
p-toluene sulphonic acid)
LLP (DCM) SPE (alumina + propylsulfonic acid) HPLC-PDA(screen)
LC-MSn (confirm)
67-9 1 0.07-0.24 [416]
MG + LMG Fish LSE (ACN, ammonium acetate buffer, hydroxylamine HCl,
p-toluene sulphonic acid)
LLP (DCM) SPE (acidified alumina) LC-MS/MS 63-90 0.1-0.2 [417]
3 Fish LSE (McIlvaine buffer + ACN) LLP (DCM) Sample mixed with SAX resin ELISA 62-108 0.05 [418]
4 Fish LSE (ACN, ammonium acetate buffer, hydroxylamine HCl,
p-toluene sulphonic acid)
LLP (H2O, DCM,
diethylene glycol)
SPE (alumina + propylsulfonic acid) HPLC-UV 49-8 8 03.-0.6 [420]
Table 23
Table 23. Examples of methods used for multi-class multi-residue analysis.
Number of
residues
Matrix Extraction
technique
Purification
technique
Additionalsample
preparation
Detection system Recovery
(%)
Sensitivity
(µg kg-1)
Ref
>100 Muscle LE (ACN:MeOH, 95:5 v/v) LLP (hexane) - LC-MS/MS 70-120 0.03-3 [12]
101 Milk LLE (ACN) Strata-X SPE - UPLC-Tof MS 80-120 <7 [13]
150 Milk LLE (ACN) Ultrfiltration - UPLC-Tof MS 60-120 0.5-25 [14]
100 Meat Bipolarity extraction Oasis HLB SPE - UPLC-Tof MS >80 1-5 [15]
38 Anthelmintics Liver and milk QuEChERS DSPE (C18) - LC-MS/MS 70-120 5 [16]
41 Chicken muscle QuEChERS (ACN + 1% HAc) DSPE (NH2) - LC-MS/MS 53-110 0.5 x MRL [17]
18 antibiotics Milk QuEChERS (ACN + 1% HAc: 0.1 M
Na2EDTA, 1:1, v/v)
No clean-up - UPLC-MS/MS 70-111 1-4 [72]
14 Bovine Muscle MSPD (C18) Elution solvent:
Hexane, Benzene,
EtOAc, MeOH
- GC + HPLC-PDA 60-94 - [74]
Antibiotics Kidney QuEChERS (ACN or
ACN:H2O [8:2, v/v])
DSPE (Silica or C18) - LC-MS/MS - - [71]
31 basic drugs Various LSE (CAN + Na2SO4)
MG + LMG from fish – LSE (citrate
buffer:ACN)
SPE (Bond Elut SCX)
Elution solvent:
ACN:35% NH3 (95:5,
v/v) + MeOH:35%
NH3 (75:25, v/v)
Fish – LLP (DCM) LC-MS, HPLC-UV,
HPLC-FL
53-104 - [112]
10 Milk LLE (20% TCA) SPE (Oasis HLB) Elution solvent:
MeOH + 5%
MeOH:2% NH3OH
LC-MS 72-97 0.48-2.64 [328]
29 Bovine muscle and kidney Enzyme digestion, LE (IPA:H2O) C18 + Oasis MAX
SPE
- LC-MS/MS ≥50 ≤1 [403]
66 Equine plasma LLE (TrichloroHAc) Bond Elut SPE - LC-MS/MS ≥60 5-500 [404]
100 Egg, fish, meat LE (ACN:H2O) Strata-X SPE - UPLC-Tof MS 70-100 - [421]
50 anabolic steroids Muscle, liver, milk Enzymatic hydrolyisis, LE (MeOH) GCB + NH2 SPE - UPLC-MS/MS 77-121 0.01-0.7 [422]
39 antibiotics Meat LE (MeOH:H2O) Dilution - LC-MS/MS 61-95 10 or 20 [423]
21 antibiotics Porcine kidney, liver,
muscle
EDTA-McIlvaine buffer Oasis HLB SPE - UPLC-MS/MS 85-120 ≤10 [424]
19 antibiotics Muscle LE (EDTA:ACN) - - UPLC-MS/MS 94-102 ≤5 [425]
19 antibiotics Muscle and kidney LE (70% MeOH) Dilution - LC-MS/MS 46-121 2-15 [426]
31 antibiotics Bovine and porcine
muscle
PLE (H2O) 70°C, 1 cycle, 10 min Mix sample + sand LC-MS/MS 75-99 3-15 [427]
25 antibiotics Milk LLE (ACN) SPE (Oasis HLB)
Elution solvent:
ACN
Ultra-filtration LC-MS/MS >50 0.25-50 [428]
18 Shrimp LSE (TCA: hydroxylamine
hydrochloride)
SPE (Oasis HLB) Elution solvent:
MeOH + MeOH:ACN
(1:1, v/v)
LC-MSn 40-90 ≤200 [429]
14 Meat MSPD (C18) Wash solvent: Elution solvent: HPLC-PDA + HPLC- 45-102 0.4-42.5 [430]
hexane DCM, EtOAc UV
19 antibiotics Muscle LE (70% MeOH) Dilution - LC-MS/MS 68-95 1-30 [431]
>100 Urine Dilute and shoot - - UPLC-Tof MS 130 ≤45 [432]
42 antibiotics Honey LLE (4 separate extractions) - - LC-MS/MS 40-90 27-80 [433]
13 Muscle LE (ACN) On-line SPE (HLB) - LC-MS/MS - 0.03-8.4 [434]
